Psound Bytes: Recent Episodes
National Psoriasis Foundation
National Psoriasis Foundation presents Psound Bytes, a podcast series featuring leading experts talking about understanding, managing and thriving with psoriasis and/or psoriatic arthritis. Listen to world renowned dermatologists and rheumatologists discuss the latest news in psoriatic disease management.
Description:
Do you wonder if TB testing is needed when on a biologic for psoriasis and/or psoriatic arthritis and why? Hear the answer to such questions and more from dermatologist Dr. G. Scott Drew as he addresses recent recommendations.
Join host Archie Franklin as he discusses the latest recommendations from NPF and the International Psoriasis Council about routine testing for tuberculosis (TB) with treatments for psoriasis and psoriatic arthritis such as TNF-inhibitors, IL-17's, IL-23's and others with NPF Medical Board member and leading dermatologist Dr. G. Scott Drew from Mid-Ohio Dermatology.
This episode identifies when a screening for tuberculosis (TB) is needed based on the type of treatment for psoriasis and psoriatic arthritis given recent recommendations from the National Psoriasis Foundation and the International Psoriasis Council.
Timestamps:
(0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. G. Scott Drew. (1:00) What is tuberculosis (TB) and why testing is required with TNF-alpha inhibitors. (4:22) Frequency of testing for TB and if false positive results occur. (6:15) Do other immunosuppressants require TB testing? (8:14) Testing may create barriers to access or unnecessary testing. (11:03) Release of new recommendations from the IPC and the NPF Medical Board offering guidance of when to test for tuberculosis prior to and during treatment of psoriatic disease. (15:37) No longer need to wait to start therapy like the IL-17's or IL-23's to see the impact on quality of life. (18:26) TB recommendations for other targeted medications like JAK inhibitors, PDE4, or the new oral IL-23 agent. (19:15) Implications of the recommendations for clinical trials. (20:13) Become a member of NPF and visit the website to access resources and stay aware of the latest information impacting the care and treatment of psoriasis and psoriatic arthritis.
Key Takeaways:
· Due to the contagious nature of tuberculosis, a mycobacteria infection that affects the lungs and other parts of the body, and the increased risk associated with suppressing TNF-alpha, a TB screening is required prior to initiating and during some treatments for psoriasis and psoriatic arthritis.
· With more advanced and targeted psoriatic disease treatments now available, the National Psoriasis Foundation and the International Psoriasis Council joint position statement recommends that TB screening is no longer needed with use of IL-17 or IL-23 treatments.
· TB screening may still be appropriate for specific populations and when symptoms are present based on a clinician's assessment.
Guest Bio:
Dr. G. Scott Drew is a medical and surgical dermatologist with Mid-Ohio Dermatology Associates where he specializes in inflammatory diseases such as psoriasis, believing strongly in dermatology and patient care. He is board certified in both Dermatology and Family Practice. In addition to his clinical practice, Dr. Drew is a member of the clinical faculty at Ohio State University, College of Osteopathic Medicine and participates in multiple dermatologic research protocols at five locations in central Ohio. He has been published in numerous peer-reviewed journals, contributed to scientific symposia, and authored textbook chapters. Dr. Drew is a fellow of the American Osteopathic College of Dermatology and the American Academy of Dermatology, he is past president of the Marion Academy of Medicine, a member of the American Osteopathic Association, and is a member of the National Psoriasis Foundation's Medical Board contributing to the development of guidelines and consensus statements. He is passionate about education providing lectures both nationally and internationally on medical, surgical, and cosmetic dermatology. Resources:
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors. Journal of the American Academy of Dermatology. Vol . 94/3; P802-809. March 2026.
Description:
How do GLP-1 receptor agonists or GIP agonists work and what is the impact for my psoriatic disease? Hear dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber answer such questions and more.
Join host Archie Franklin as he takes a deep dive into the use of GLP-1 receptor agonists and GIP agonists and the convergence of systemic inflammation related to psoriatic disease with renowned dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and, cardio-immunologist Dr. Brittany Weber, Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. Learn more about the use of incretin hormones, the impact of weight management on psoriatic disease, metabolic and cardiovascular risk, as well as results from the TOGETHER-Pso and TOGETHER-PsA clinical trials.
This episode addresses the actions of incretin hormones (GLP-1 receptor agonist and GIP agonist) and how such use may be beneficial in the management of inflammation related to psoriasis and psoriatic arthritis.
Thank you to Lilly for their support of this program activity.
Timestamps:
(0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber.
(1:35) What are incretin hormones and how GLP-1 or GIP receptor agonists (RA) inhibit appetite to initiate weight loss.
(3:29) Why GLP-1 RAs are of interest in the management of psoriasis and psoriatic arthritis.
(5:23) The metabolic, cardiovascular, and psoriatic disease convergence.
(7:19) Will reduction of inflammation impact cardiovascular risk?
(10:59) Treatment challenges associated with having psoriatic disease and being overweight or obese.
(13:45) Key points around the use of GLP-1 receptor agonists when managing psoriasis and psoriatic arthritis.
(17:06) Results of the TOGETHER-PsO and TOGETHER-PsA phase 3 clinical trials combining use of an IL-17 inhibitor and a GIP and GLP-1 receptor agonist therapy.
(19:07) Having the conversation of adding a GLP-1 RA medication to a treatment regimen.
(22:40) The paradigm shift of GLP-1 receptor agonists and the impact they can have on shared inflammatory pathways.
Key Takeaways:
· Glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP) agonists are two incretin hormones that assist in managing excess body weight -- which as a result can be helpful in managing inflammation in the body.
· Psoriasis isn't just a skin and joint disease. It's a complex network of systemic inflammation with shared inflammatory pathways that worsens with increased weight impacting the severity of the disease, and accelerates the risk of metabolic dysfunction, and cardiovascular disease.
· The best outcomes occur as a result of multidisciplinary collaboration to address the impact of excess weight and systemic inflammation. If you are struggling to lose weight with diet and exercise, speak with your medical team about your options including the use of GLP-1 or GIP agonists.
Guest Bios:
Renowned dermatologist Ronald Prussick, M.D., Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland, specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health, first becoming interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET/CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick has since participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis and more recently the position statement "GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board". Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and education oversight to the organization and its Executive leaders.
Brittany Weber, M.D., Ph.D. is a cardio-immunologist who is the Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. She is also a member of the Division of Cardiology, a clinical investigator, and imaging specialist. Dr. Weber's research integrates advanced imaging, molecular biology, clinical trials, and population health to understand how systemic inflammation and immune deregulation drives cardiovascular dysfunction. Prior to joining UT Southwestern in 2025, Dr. Weber served on the faculty at Harvard Medical School and was the Director of the Cardio-Rheumatology Clinic at Brigham and Women's Hospital, a nationally recognized clinic addressing inflammation-related heart disease through collaborative, patient centered care. Dr. Weber is also an author on the position statement "GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board".
Resources:
"The Metabolic Collison and How You Can Take Control with Psoriatic Disease" podcast episode with dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan
"NPF Medical Board Issues GLP-1 Primer for Dermatologists" Press Release
"Finding My Path to Managing Psoriatic Disease and Excess Weight" podcast episode featuring dermatologist Dr. Erin Boh, patient advocate Brian Lehrschal, and moderator Jennifer Bomberger.
Description:
"When joint pain is present, the diagnosis of psoriatic arthritis needs to be made as soon as possible, ideally within six months to limit joint inflammation" Dr. Vinod Chandran mentions as he discusses efforts to identify a diagnostic test for those at risk of developing psoriatic arthritis.
Join host Jeff Brown as he speaks with leading rheumatologist and clinician scientist Dr. Vinod Chandran, Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto to learn more about the progress and promising results towards developing a psoriatic arthritis diagnostic test through multi-omic assays and identifying the distinct differences between psoriasis and psoriatic arthritis.
This episode provides an update on the progress to date of the NPF PsA Diagnostic Test grant initiative which has shown promising results with a potential test entering prospective study in multiple sites soon.
Thank you to Johnson and Johnson for their support of this program activity.
Timestamps:
(0:00) Intro to Psoriasis Uncovered & guest welcome rheumatologist Dr. Vinod Chandran.
(0:52) It is challenging to diagnose psoriatic arthritis with many factors leading to a delay in diagnosis.
(4:56) The start of Dr. Chandran's involvement with the PsA Diagnostic Test Grant project.
(7:55) The different types of omics and the definition of multi-omic.
(9:57) How the multi-omic approach is used to find biomarkers relative to a specific disease pattern.
(11:08) Development of a predictive or prevention-based test using gene expression.
(13:46) First year results identify 200 markers across different omic approaches that distinguish psoriatic arthritis from psoriasis.
(14:58) The significance of MRNA vs mIcroRNA's use in development of a diagnostic test and how critical that is to dissemination of a potential test.
(17:08) Identifying the skin-joint axis in relation to different types of arthritis.
(20:20) Next steps to moving the diagnostic test research forward as a prospective study in multiple sites and the cost effectiveness of delivering the test.
(23:13) If you have psoriasis, musculoskeletal, back, and joint pain think of psoriatic arthritis and be diagnosed early to maintain a good quality of life.
Key Takeaways:
· Given challenges associated with diagnosing psoriatic arthritis and the impact on quality of life, in 2019 NPF launched the PsA Diagnostic Test Grant project with the goal of developing an early stage test that would identify and diagnose those with psoriatic arthritis before debilitating joint damage begins.
· Progress towards a PsA Diagnostic Test includes the study of multi-omic data sets where 200 distinct biomarkers have been identified leading to a greater understanding of the different pathways between psoriatic arthritis, psoriasis, and the skin joint axis.
· A potential diagnostic test is now moving towards the prospective study phase. Until the test is available and if joint pain is present and you have psoriasis, ask your health care provider if it could be psoriatic arthritis and treat appropriately.
Guest Bio:
Vinod Chandran, MBBS, MD, DM, PhD is a rheumatologist, clinician scientist, and Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto where he is also a Professor of Medicine. His specialties include internal medicine, immunology, rheumatology, and genetic epidemiology. His research focus is on the development of biomarker-based strategies to improve early diagnosis and prognosis of psoriasis and psoriatic arthritis, identification of new treatment targets especially for those who do not respond to current therapies, and strategies to reduce the impact of disease. Dr. Chandran is a Co-Vice President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis or GRAPPA. He is an active collaborator in a multi-center research consortia such as the International Psoriasis and Arthritis Research Team and the Spondyloarthritis Research Consortium of Canada. Dr. Chandran is the recipient of research funding from the National Psoriasis Foundation for his work in identifying a "Multi-omic Diagnostic Test for PsA in Psoriasis Patients".
Resources:
"Understanding the NPF Psoriatic Arthritis Diagnostic Test Grant Outcomes" Advance Online. February 18, 2026.
"Managing Chronic Pain with Psoriatic Arthritis" Psoriasis Uncovered podcast episode with physiatrist Dr. Erin Maslowski, LB Herbert who lives with psoriatic disease, and moderator Susan McClelland-Tobert, a retired pediatric cardiologist who also lives with psoriatic disease.
Glossary of terms:
mRNA: Messenger RNA carries protein information or instructions from the DNA in a cell's nucleus to the cell's interior where the sequence is read and translated into corresponding amino acids for growing protein chains.
Micro-RNA (miRNA): Micro-RNA act as the regulator. They are short and bind to specific target mRNA's to degrade or inhibit production of protein.
Description:
"What is metabolic disease and why do I have it on top of psoriatic disease?" Hear dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan explore this collision of diseases and how you can take control to help reduce the impact of inflammation.
Join host Corinne Rutkowski as she discusses why metabolic disease occurs with psoriasis and psoriatic arthritis and what can be done to improve overall health with dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and Danielle Cahalan, a registered dietitian and coach with All Access Dietitians. Listen as they also discuss the four pillars of health, the latest evidence around use of the Mediterranean Diet with psoriatic disease, key nutrients that impact overall health from omega 3's, polyphenols, and fiber, to making small sustainable changes.
This episode offers information to help explain the connection between metabolic and psoriatic disease and what can be done to decrease health risks associated with both diseases through sustainable changes.
Timestamps:
(0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and registered dietitiand and coach Danielle Cahalan.
(1:27) Definition of metabolic disease and why the risk is higher among those with psoriasis or psoriatic arthritis.
(3:11) How this bi-directional relationship impacts the management of psoriasis and psoriatic arthritis.
(6:54) The four pillars of health that can be used to reduce the risk of metabolic disease.
(11:17) Does an anti-inflammatory diet exist?
(13:46) What is the Mediterranean diet and the foods that are typically included.
(16:32) The impact of the Mediterranean diet on systemic inflammation, metabolic health, and severity of psoriatic disease.
(21:03) The three types of healthy fats – what they are, how they work, and where to find them.
(24:50) The high polyphenol Mediterranean diet from what that means to choosing nutrient dense, colorful foods.
(28:04) The koebnerization of the gut microbiome and the impact of the Mediterranean diet and high fiber.
(30:59) The DASH diet in combination with the Mediterranean diet lowers oxidative stress and inflammation.
(33:14) Sustainability of the Mediterranean diet and flexing behavioral health changes long term.
(37:43) Start with small habit changes and then build from there to have an impact on your metabolic health.
Key Takeaways:
· Research shows a bi-directional relationship between psoriasis and excess body weight leading to increasing severity of disease, decrease in treatment effectiveness, and the development of metabolic syndrome, a group of conditions which together raise the risk of coronary heart disease, stroke, and diabetes.
· What you choose to eat can make an impact in managing inflammatory markers, metabolic health to increase insulin sensitivity, decrease high blood pressure, improve lipids and the gut microbiome, as well as support neuro protection and decrease cognitive decline.
· Create small sustainable habits that make positive changes to your immune system and gradually work towards building a foundation that benefits your overall health.
Guest Bios:
Renowned dermatologist Ronald Prussick, M.D. is the Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland where he specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails with the latest technology and products. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health. He first became interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET?CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick also participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the NPF, which offered a review of studies addressing the impact of dietary interventions in people with psoriasis and psoriatic arthritis. Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and provides education oversight to the organization and its Executive leaders.
Danielle Cahalan, MS, RDN is a licensed and registered dietitian and coach with All Access Dietitians which offers virtual nutrition support services in AZ, CA, CO, CT, FL, IL, IN, MA, MO, MT, NJ, NY, NC, OR, PA, SC, TX, VA, WA, WI, and WY. All Access Dietitians infuses the science of motivation, habit formation, and sustainable behavior change into every session that addresses weight management and metabolic health, to women's health and digestive support. Danielle's primary focus during sessions is to help her clients find that intersection between enjoyment and satisfaction with their food choices that also support their health through sustenance. It's about finding that balance between feeling empowered, energized, and confident in the ability to make decisions that impact health, wellness, and longevity.
Resources:
"Mediterranean Diet Pyramid: Guidelines for Healthy Eating" © 2009 Oldways Preservation and Exchange Trust www.oldwayspt.org and UCSF Weill Institute for Neurosciences Memory and Aging Center.
DASH Eating Plan (Dietary Approaches to Stop Hypertension). February 25, 2026. NIH (National Heart, Lung, and Blood Institute)
Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial. AMA Dermatology . Dec. 1, 2025
The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients Journal of Psoriasis and Psoriatic Arthritis 2024 Jan 9.
Description:
Coping with psoriasis can be challenging when your routine changes. Hear NPF Youth Ambassadors Aditi, Alyssa, and Pierce offer what they do to overcome such challenges when out of their routine.
Join host Kaleigh Welch as she discusses tips for coping with changes that occur when traveling to visit family or friends, going on vacation, camping, or a change in schedule with three amazing NPF Youth Ambassadors Aditi, Alyssa, and Pierce who live with psoriasis. Hear their story from challenges with their initial diagnosis, struggles with insecurities, whether they choose to inform others, and what they do to manage their disease and stress while living their life with confidence to pursue their chosen activities no matter if their routine changes.
This episode features how 3 NPF Youth Ambassadors overcome challenges when out of their routine and how they respond while managing their psoriasis.
(0:00) Intro to Psoriasis Uncovered & welcome to guests Youth Ambassadors Aditi, Alyssa, and Pierce.
(0:55) Overcoming challenges from diagnosis, finding the right treatment, to making choices impacted by living with psoriasis.
(5:44) Tips for what to do and pack when traveling for activities that disrupt the usual routine.
(10:11) Keeping the skin moisturized can be a challenge but find a routine and product that works.
(12:38) Preparing for potential triggers that could initiate the Koebner phenomenon and psoriasis.
(13:33) Managing the impact of stress when out of the routine or traveling.
(16:20) Alyssa's approach to managing fatigue.
(16:53) The impact of diet and exercise when managing psoriasis.
(18:47) Telling others about psoriasis when staying at a friend's house or hotel.
(23:36) Our number one recommendation for when being out of your routine.
(25:39) Be confident about who you are and trust you'll find the right treatment and routine for your psoriasis.
Key Takeaways:
· Being out of your normal routine whether traveling on vacation or for work, camping, staying at a hotel or with family or friends can present challenges to managing your psoriasis.
· Preparing in advance by anticipating medication or over-the-counter needs, telling others, and asking for help can reduce the impact of challenges due to a change in routine.
· Be confident about who you are, find a treatment that works, and learn to live successfully with your psoriasis.
Guest Bios:
Aditi enjoys Carnatic singing, violin, figure skating, and participating in Model UN where students debate global issues, learn diplomacy, international relations, and public speaking. Aditi was diagnosed with psoriasis at 10 years old and has used topicals to manage her disease along with diet, exercise and stress management. Prior to becoming a Youth Ambassador she had never met anyone with psoriasis. She plans to pursue a career in dermatology.
Alyssa is relatively new to the NPF Youth Ambassador program, joining in 2025 to connect with others who also live with psoriasis. Her diagnosis process was challenging and eventually she was diagnosed with guttate psoriasis after being improperly diagnosed and given treatments that didn't fully clear her psoriasis. This experience changed her life both physically and emotionally. Alyssa is a busy student-athlete serving as a member of her school's varsity cheer team and being a star pitcher for her school's softball team.
Pierce connected with NPF right after being diagnosed with moderate to severe plaque psoriasis in 2024 which covered over half of his body. Together with his mother they learned more about the disease and management with various treatment options from NPF, quickly learning what worked and what didn't. Per Pierce "it was horrible dealing with it for a while because I couldn't hide the plaques." After facing challenges with step therapy and eventually traveling to the Mayo Clinic he found the treatment he needed to help clear his skin. Pierce is very active in golf playing at least 5 days a week. He currently plays for his high school team, the Louisiana Junior Golf Tour, and the American Junior Golf Association (AJGA). Pierce also became a Youth Ambassador to meet others with psoriatic disease.
Resources:
-Meet other teens who have psoriatic disease. Become a Youth Ambassador
-"Traveling Near and Far With Psoriatic Disease" podcast episode.
-"Moisturizing Sensitive Skin" Advance Online. June 11, 2025.
After being diagnosed with psoriasis and psoriatic arthritis, finding a community that understood how life changed meant everything to Jody Quinn, Ben and Kathryn Rifenbark.
Join host Alan Simmons as he addresses life with psoriasis and psoriatic arthritis before and after finding the National Psoriasis Foundation with 3 amazing volunteers – Jody Quinn, Ben and Kathryn Rifenbark. Hear their story from struggles with initial diagnosis, being an advocate for their own health care, to how they chose to become part of a community and help others with the disease to support the mission of the National Psoriasis Foundation. Being part of NPF truly changed their lives!
This episode features how 3 volunteers changed their lives to navigate the challenges of being diagnosed with psoriatic disease to taking steps to help others in need and the mission of the National Psoriasis Foundation.
Timestamps:
· (0:00) Intro to Psoriasis Uncovered & guest welcome Jody Quinn, Ben and Kathryn Rifenbark.
· (0:59) What life was like for Ben and Kathryn from diagnosis to finding a community through NPF.
· (2:42) Facing psoriatic arthritis first and being undiagnosed for years was challenging for Jody.
· (4:48) Finding control over psoriatic disease by becoming an advocate for change.
· (6:15) Diving into the deep end to help fundraising efforts.
· (7:03) Becoming a One to One mentor to help answer questions from others and share the positive impact NPF makes in our lives.
· (8:52) Making connections to help raise awareness about psoriatic disease from resolutions to public service
announcements and lighting bridges in NPF's colors -- orange and blue.
· (10:40) Receiving the NPF Volunteer Innovator award and being a Psoriatic Ambassador Honoree.
· (12:04) Benefits we received from attending the IMPACT Summit Volunteer Leadership Conference.
· (15:11) Jody's single most life-changing event was attending the FDA Drug Development meeting.
· (17:23) It's important to advocate for your own health care needs while continuing to learn from others and resources
available through the NPF.
· (19:14) Every step no matter how small or large makes an impact and is important.
Key Takeaways:
· Being diagnosed with psoriasis and psoriatic arthritis is a life-long journey which can be made easier by finding the right health care, education and resources, as well as a community that understands what it means to live with psoriatic disease. You are not alone.
· You can take control over your disease by advocating for policy changes that affect all patients regardless of what chronic disease they may have. Let your voice be heard.
· Every step you take no matter how small or large makes a difference – whether it's learning more about psoriatic disease, sharing your story, or participating as a volunteer. You can make an impact. Start your journey with NPF today! Become a volunteer.
Guest Bios:
Jody Quinn has a long history of involvement with NPF as a volunteer. She first became a volunteer in 2012 after seeking to connect with others who have psoriatic disease during a Walk event. She remembers meeting an inspirational group of volunteers. Wanting to learn more about her disease she attended More Than Skin Deep and Be Joint Smart events and served as a moderator. Continuing her path of involvement she attended Volunteer Conferences in Chicago and San Francisco. In 2016 she attended her first Capitol Hill Day followed by the FDA Patient Focused Drug Development (PFDD) meeting. Her involvement was so profound she remains an active advocate promoting research and legislation to enhance access to treatments and health care services. Jody has been so successful in promoting awareness about psoriatic disease, she was awarded the NPF Volunteer Innovator Award in 2017. In 2025 she was also named as the New England Soiree Psoriatic Ambassador Honoree for her impactful service and tireless advocacy. In her words, "I volunteer because it gives me some control over what often feels like a completely uncontrollable disease. It allows me to have a say in what is happening with my life and my disease, which I didn't have before. I also volunteer so that others don't have to go through the same long and difficult journey to diagnosis and treatment that I did."
Kathryn & Ben Rifenbark discovered the NPF after many challenges with finding the right diagnosis for Ben's psoriasis. Through a local NPF Take ACTION event Ben quickly learned he wasn't alone in living with his disease, while Mom, Kathryn, gained as much information as she could. After the event, they soon became part of the NPF community with Ben serving as the 2024 Take ACTION Ambassador and a leading peer-to-peer fundraiser. He shared his story and a motivational message at last year's Take ACTION event to help encourage others to support the mission of the NPF. Ben is also an IMPACT Ambassador learning how to advocate for himself and has participated in the IMPACT Summit representing the amazing youth who are part of our NPF Community. Kathryn is now a mentor sharing what she's learned with other parents.
Resources:
Volunteer Spotlight: Jody Quinn May 1, 2025
Ambassador, Advocate and Mentor Advance Online December 11, 2025. (Ben & Kathryn Rifenbark)
Her Nails Held the Secret to Her PsA Advance Online Updated September 29, 2025.
Description:
Learn why advocating for care is crucial when moderate to severe plaque psoriasis develops at a young age or in high-impact sites, and how advanced biologic therapies can offer effective solutions for those that may be undertreated.
Join moderator Kaitlin Walden, patient advocate Carolyn, and dermatologist Dr Candrice Heath as they discuss the realities of living with moderate to severe plaque psoriasis at a young age, as well as adult patients with plaque psoriasis in high-impact sites, like the scalp, nails, and face. Carolyn shares her personal journey with moderate to severe plaque psoriasis and how it has continued from childhood into adulthood, while Dr Heath offers insights to help caregivers and patients navigate treatment approaches, including when and how a biologic therapy may be helpful.
This episode addresses challenges associated with living and treating moderate to severe plaque psoriasis in children and adults.
This episode is sponsored by Johnson & Johnson. Please see Important Safety Information and full Prescribing Information for the product mentioned in this episode.
Timestamps:
· (0:23) Intro to Psoriasis Uncovered and guest introductions from dermatologist Dr. Candrice Heath and Carolyn, a patient advocate living with plaque psoriasis and psoriatic arthritis.
· (1:22) Information about, and pivotal data for, TREMFYA® (guselkumab), a biologic used to treat adults and children 6 years and older who weigh at least 88 lbs or 40 kilograms with moderate to severe plaque psoriasis.
· (3:48) Living with psoriasis as a child can be difficult with challenges in being diagnosed correctly and receiving appropriate treatment.
· (6:17) A dermatologist's view of children and adolescents living with plaque psoriasis including in high-impact sites.
· (8:14) It's important to advocate for yourself and the best possible care.
· (9:37) Open communication with your dermatologist helps identify the best possible treatment plan, which is dependent on several factors including the availability of new treatment options.
· (12:05) Carolyn's biggest challenge is managing her psoriasis and then psoriatic arthritis.
· (14:20) Results of the SPECTREM clinical trial addressing treatment of adults with moderate plaque psoriasis in high-impact sites.
· (17:38) Find the support and information you need to find the right treatment.
· (21:48) Important Safety Information about TREMFYA® (guselkumab).
Key Takeaways:
· Plaque psoriasis can be challenging both physically and emotionally for children and adults – especially when high-impact site involvement (such as the face, scalp, armpits, and groin) is present.
· Individual treatment plans vary and are based on several factors, including the severity of psoriasis, dosing schedule, cost, or route of administration. Finding the right treatment for plaque psoriasis is a collaboration between a dermatologist, the patient, and/or family (should the patient be a child).
· A number of medicines that treat plaque psoriasis from the inside out, including biologics, are now available for children and adults. Such treatment options are continuing to expand.
Guest Bios:
Candrice Heath, M.D. is a highly respected triple board-certified dermatologist who sees both children and adults at Howard University Hospital in Washington DC where she is also an Associate Professor in the Department of Dermatology. She is board-certified in dermatology, pediatrics, and pediatric dermatology.
Dr Heath is a nationally recognized speaker, pediatric and adult dermatology clinical researcher, and has held a variety of leadership roles including Chair for the Pediatric Dermatology Research Alliance (PeDRA), Skin of Color and Pigmentary Disorders Focused Group, Skin of Color Society National Secretary-Treasurer, and American Academy of Dermatology Diversity Committee member. Her clinical, research, and teaching interests are shaped by insights gained from her unique practice filled with both children and adults in addition to her passion for exploring the intersection of dermatology and social science.
Carolyn Pugh is a patient advocate and volunteer with the National Psoriasis Foundation who lives with psoriasis and psoriatic arthritis. Carolyn was diagnosed with psoriasis at age 11 after being misdiagnosed and offered treatments that didn't work. Once she was diagnosed with plaque psoriasis some of the initial treatments were difficult and unsustainable. Over the years she has learned to advocate for her own self-care and feels her personal experiences can help empower other adults and parents.
Resources:
· Learn more about treatment options for children and adolescents at Our Spot for Youth and Parents
· For more information about psoriasis in high-impact sites
Hear leading dermatologist Dr. E. James Song and patient advocate Ana Rinck share their perspectives on the use of biosimilars to manage psoriasis and psoriatic arthritis.
The use of biosimilars is growing with 24 currently on the market and more on the way for the treatment of psoriasis and psoriatic arthritis. What does this mean for you? Find out as we explore the use of biosimilars, the impact of interchangeability, what it's like switching to a biosimilar, and what questions to ask your health care provider with leading dermatologist and NPF Medical Board member Dr. E. James Song, Director of Clinical Research at Frontier Dermatology Partners, and patient advocate Ana Rinck who currently uses a biosimilar to treat her psoriasis and psoriatic arthritis.
The intent of this episode is to offer an update on the use of biosimilars and to hear the experience of those who have used biosimilars to manage psoriatic disease.
This episode is sponsored by Organon. Timestamps:
(0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. E. James Song, Director of Clinical Research and Co-Chief Medical Officer, Frontier Dermatology, and patient advocate Ana Rinck, who presents her experience with using a biosimilar to treat psoriasis and psoriatic arthritis.
(0:58) Definition of what is a biosimilar in comparison to a biologic which is also referred to as the original bio-originator or reference product.
(3:10) What biosimilars are available and how they are used.
(4:35) The term interchangeable and what it means for use of a biosimilar.
(5:46) Ana's diagnosis to treatment options starting with use of topicals to ultimately use of a biosimilar.
(7:57) Treatment discussion and choices when faced with diminishing effectiveness within a class of medications. Should a biosimilar be considered as an option?
(9:50) Questions to consider when there's a change in treatment.
(10:57) FDA announcement to simplify the development process for biosimilars and what that means for the future use of biosimilars.
(13:55) What to consider when thinking of a biosimilar as a treatment option and where to find help when needed.
(14:53) The hope and equity of access that biosimilars represent is here for the appropriate individual.
Key Takeaways:
· A biosimilar is an FDA-approved biologic product that behaves and functions like a brand biologic treatment which is also called the reference product or bio-originator. There are no clinically meaningful differences between biosimilars and their reference product.
· The FDA has approved several biosimilars for the treatment of psoriasis and psoriatic arthritis. Some have been identified as interchangeable which means a biosimilar could be substituted for a reference product without a health care provider's approval pending state legislative rules.
· Don't be afraid to ask questions or access resources to assist with preparing for a medication change should that change be initiated either by yourself, your healthcare provider, or your health insurance company.
Guest Bios:
E. James Song, M.D. is a nationally recognized dermatologist and clinical researcher who is also a Clinical Instructor at the University of Washington. Dr Song is recognized as a key opinion leader in treating psoriasis and atopic dermatitis. He is actively involved in the development of new therapies for dermatologic disease and has firsthand experience with treatments before they come to market. Dr. Song has been published extensively in peer review journals and regularly participates in meetings both as a lecturer and attendee. He is also a Medical Board member of the National Psoriasis Foundation. He believes that the best health outcomes come from shared decision making between the patient and physician. Dr. Song strives to help patients understand not only their condition, but all their treatment options.
Ana Rinck is a patient advocate and volunteer for the National Psoriasis Foundation. She developed psoriasis in 2009 following symptoms she noticed for a few years which proved to be challenging to diagnose. She managed for many years on topicals and intralesional injections. In 2018 she was diagnosed with psoriatic arthritis and started use of a biologic realizing she needed to protect her joints from further damage. She now uses a biosimilar to manage her psoriatic disease. Ana owns her own private consulting business and is an Operations and Project Manager.
Resources:
-Learn more about biosimilars, interchangeability, and state substitution rules.
-Armstrong A, Callis Duffin K, Feldman S, Glick B, Kalb R, Reddy S, Schwartzman S, Yamauchi P, Calabrese C, Cordoro K, Desai S, Gladman D, Han G, Hawkes JE, Hsu S, Kircik L, Koo J, Kreuger GG, Lebwohl M, Leonardi C, Lewitt GM, Liao W, Liu C, Markenson J, Merola JF, Orbai A, Prussick R, Richardson V, Soung J, Van Voorhees AS, Wallace E, Weinberg J, Wine Lee L, Harris J, Koons S, Howard L. Position Statement on the Use of Biosimilars for Psoriasis and Psoriatic Arthritis. National Psoriasis Foundation Medical Board. 2023.
-If you need help finding a dermatologist near you contact the NPF's Patient Navigation Center for assistance.
Description:
Nail psoriasis is tough to treat. Hear Rebecca, a patient who lives with nail psoriasis, and dermatologist Dr. Paul Yamauchi discuss the diagnosis, care, and treatment for this high-impact site.
Join host Roy Pankey as he addresses the complexities of nail psoriasis from diagnosis to coping and the latest research and treatments with leading dermatologist, Dr. Paul Yamauchi from the Dermatology Institute and Skin Care Center and Clinical Science Institute, and Rebecca, a patient advocate with the National Psoriasis Foundation who lives with nail psoriasis. Listen as they discuss the challenges associated with living with nail psoriasis, and what can be done to help manage the disease from self-care to treatment choices – including the latest research developments.
While nail psoriasis can be challenging to diagnose and treat, there are many actions that can be taken to help minimize the impact of this disease.
Timestamps:
(0:00) Intro to Psoriasis Uncovered & guest welcome Rebecca and dermatologist Dr. Paul Yamauchi. (0:58) Signs or changes to nails that indicate nail psoriasis is present. (2:07) Elements and challenges to diagnosing nail psoriasis. (4:41) What is a nail biopsy and how is it done. (5:25) How nail psoriasis relates to psoriatic arthritis. (6:19) What flares my nail psoriasis. (6:57) There are many treatment choices used to treat nail psoriasis based on convenience, impact of disease, preference, and when to expect improvement. (10:13) A personal perspective on medications used to treat nail psoriasis. (10:42) Research results of the latest medications used to treat nail psoriasis. (13:03) Upcoming oral agents that could be effective in treating nail psoriasis. (15:14) Self care tips, use of nail polish and artificial nails. (19:21) Nail psoriasis is challenging to treat. Be patient with yourself and your dermatologist.
Key Takeaways:
· Nail psoriasis presents many challenges from living and coping with the disease to diagnosis and treatment.
· Medication choices for nail psoriasis are based on convenience, impact of disease, and preference for use of topicals, phototherapy, oral agents, and/or biologics.
· Since nail psoriasis takes time to see improvement, it is important to be patient with yourself and your dermatologist.
Guest Bios:
Dermatologist Dr. Paul Yamauchi is President and Medical Director of the Dermatology Institute and Skin Care Center and Clinical Science Institute in Santa Monia, CA. Dr. Yamauchi is a leading expert in the field of psoriasis and has extensive experience treating different types of psoriasis using the latest treatments from topicals to biologics. He is also a Clinical Professor in the Division of Dermatology with David Geffen School of Medicine at UCLA. Dr. Yamauchi has conducted over 200 clinical research trials as principal investigator and is widely regarded as an outstanding clinical research investigator exploring innovative therapies, serving on advisory panels designing protocols that led to FDA approval of various medications. Dr. Yamauchi is a past member of the Medical Board of the National Psoriasis Foundation and is a fellow of the American Academy of Dermatology, and the American Society of Dermatology Surgery.
Rebecca Cohen, is a patient advocate, who was diagnosed with plaque, scalp, and nail psoriasis at age 6 after being adopted by a dermatology physician's assistant who quickly found the best treatment path for her. Prior to that time she was told she had eczema. "My skin actually was really bad as a child. Horrible. Hands, feet, elbows, everything." Eventually after experiencing joint pain and fatigue, she was also diagnosed with psoriatic arthritis around age 20 at which time she started on her first biologic. "I struggled a lot with nail pitting and thickness as a kid and have recently been going through another episode."
Resources:
-Still have questions? Contact the Patient Navigation Center .
-Nail Psoriasis or Nail Fungus? Advance Online June 2025.
-What Your Nails Can Tell Your Doctor About PsA Advance Online March 2020 .
"Help! It's winter and my psoriasis and psoriatic arthritis is flaring." Listen as certified physician assistant Eileen Cheever offers tips to help manage psoriasis and psoriatic arthritis flares that occur during the winter months.
Join host Corinne Rutkowski as she explores tips for managing psoriasis and psoriatic arthritis when cold weather flares the disease with Certified Physician Assistant Eileen Cheever from Clearview Dermatology. Listen as they discuss why flares occur and tips for improving flares from humidity, moisturizing products even for palmoplantar psoriasis, types of fabrics to layer, addressing aches and pains with psoriatic arthritis, use of rescue therapy, to stress and mood changes.
This episode offers information to help address winter flares that may cause you to struggle with your psoriatic disease during cold weather.
Timestamps:
(0:00) Intro to Psoriasis Uncovered & guest welcome Certified Physician Assistant Eileen Cheever.
(1:15) Definition of a psoriasis or psoriatic arthritis flare.
(2:32) How cold weather could be connected to winter flares of psoriatic disease.
(4:11) Tips for addressing dryness and lack of humidity in the home.
(6:13) Products that help moisturize your skin and when is the best time to apply it to your skin.
(8:56) Products for moisturizing the hands and feet with palmoplantar psoriasis.
(12:33) Types of fabrics to layer in the winter to help decrease the itch while staying warm.
(14:15) Tips for addressing the aches and pains that come with cold winter months.
(16:22) Medication changes vs use of rescue therapy for treating a winter flare.
(17:51) Tips to help manage overall health, stress, and mood.
(21:37) Reach out to your health care provider if you are struggling with your psoriatic disease.
Key Takeaways:
· While we don't completely understand the connection, 4 out of 10 people identify winter as the season that flares their psoriasis.
· Factors that contribute to cold weather flares include lack of moisture or humidity in the air, viruses or flu, long heated showers that lead to dry, itchy skin, itchy fabrics, stress, and depression with dark days.
· Strategies to address winter flares include various moisturizing products, maintaining 60% humidity, choosing breathable fabrics, lifestyle choices, and keeping your dermatologist and rheumatologist informed should rescue therapy be needed.
Guest Bio:
Eileen Cheever is a certified dermatology physician assistant (PA-C) with a clinical practice at Clearview Dermatology where she treats adults and children with a variety of diseases of the skin, hair, and scalp including psoriasis. She is a diplomate member of the Society of Dermatology Physician Assistants, a founding advisory board member for Elevate Medical Education, a member of the American Academy of Physician Assistants, and a member of the NPF Advanced Practice Provider (APP) Advisory Committee. She has a passion for providing education and lectures frequently at dermatology conferences across the country.
Resources:
Seasonal Flares Guide. National Psoriasis Foundation 2023©.
8 Must-Have Lotions. Advance Weekly. Updated September 30, 2025.
"Managing Chronic Pain with Psoriatic Arthritis" podcast episode addressing why pain occurs, its
impact, and what can be done to manage pain both physically and emotionally.
Description:
In this episode hear board-certified dermatologist Dr. Omar Noor and special guest, music icon Art Garfunkel discuss management of and living with moderate to severe plaque psoriasis.
Join us for this special episode of Psoriasis Uncovered as music icon Art Garfunkel shares his personal journey with moderate to severe plaque psoriasis. Alongside renowned dermatologist Dr. Omar Noor and moderator Max Blitstein, Art shares insights on his diagnosis, how psoriasis has impacted his musical career, and his experience using the treatment Ilumya (tildrakizumab-asmn). Tune in to explore the intersection of melodies, medicine, and advocacy, and gain inspiration for living with psoriasis.
The intent of this episode is to share Art Garfunkel's story of living an active music career with plaque psoriasis and how he eventually found a treatment that works for him.
This episode is sponsored by Sun Pharma . For important safety information: https://bit.ly/2We7fIS
Timestamps:
(0:23) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. Omar Noor, Co-Owner Rao Dermatology, and special guest, music icon, poet, author and actor Art Garfunkel who lives with plaque psoriasis.
1:04 Psoriasis came quietly into Art's life but wasn't easy.
1:36 Art's life on the road touring and being in the spotlight with psoriasis.
2:50 Having a strong support system is just as important as managing the physical symptoms of psoriasis.
3:59 A personalized approach to treatment options is possible when having an open dialogue with your doctor. You don't have to face the challenge of living with moderate to severe plaque psoriasis alone.
5:27 What to expect when using Iluyma®, a biologic given 4 times a year.
8:54 Art's message to anyone newly diagnosed with plaque psoriasis who feels overwhelmed.
9:20 Your treatment plan is a collaborative decision between you and your health care provider and stay informed with reliable evidence-based resources.
10:57 Closing comments and where to learn more information about Iluyma®.
11:39 Important Safety Information about Iluyma®.
Key Takeaways:
· Living with psoriasis can be a private struggle with challenges to overcome both physically and emotionally but know that you are not alone.
· Since no two people are alike and given the variety of available treatment options, tailoring treatment options to the needs of an individual's lifestyle is possible.
· Open communication between you and your health care provider is key to finding the right treatment for you.
Guest Bios:
Art Garfunkel is a music legend, poet, author and actor who has received numerous awards and honors throughout his life including being inducted into the Rock & Roll Hall of Fame. Internationally recognized for having a distinctive voice as part of the duo Simon & Garfunkel and later Garfunkel & Garfunkel, he inspired many with his melodies and rhythms. But behind the harmonies and stage lights he was struggling to live with the challenge of moderate to severe plaque psoriasis feeling isolated and depressed. Finding the right treatment after years of struggling, Art hopes to inspire others through his story saying "There's real power in speaking our truths. Vulnerability, as it turns out, is not weakness, it's connection. And connection is healing. Take a breath. You will find your way through this."
Omar Noor, M.D. is a board-certified dermatologist and co-owner of Rao Dermatology in New York and New Jersey. He started his dermatology career as a partner in his practice with a focus on medical dermatology, having a clinical interest in psoriasis and atopic dermatitis. Dr. Noor has received several awards from the New York Academy of Medicine in the field of dermatology. He currently serves as a member of the Editorial Advisory Board for Dermatology Times and the NYC Medical Reserve Corp.
Resources:
- "Embracing Resilience", Read more about Art's story at Advance Online, National Psoriasis Foundation. August 26, 2025.
- Learn more about psoriasis from types, symptoms, typical locations, to diagnosis and life with psoriasis.
Description:
Psoriatic disease affects far more than just the skin. Hear leading dermatologist Dr. April Armstrong and Dr. Benoît Guérrette discuss this and more with Jensen, a patient advocate.
Psoriatic disease affects not only the skin but it can impact confidence, emotional and social well-being, and daily life. In this episode, join moderator Dr. Guy Eakin, Chief Scientific and Medical Officer at NPF, as we explore the disconnect between clinical classifications of psoriasis and what patients experience in real-life with leading dermatologist Dr. April Armstrong, Dr. Benoît Guérrette, Vice President of Dermatology & Rheumatology at Takeda, and Jensen, a NPF patient advocate and former Lead Youth Ambassador. Listen as we address the need for a more nuanced approach to classifying disease severity that accounts for the holistic needs of psoriatic disease, as well as share insights into how advocacy and awareness can drive change in treatment access and care standards.
The intent of this episode is to identify how clinical severity classifications of psoriasis are evolving to meet the needs of those who live with the disease and how that change impacts overall management.
This episode is sponsored by Takeda.
Timestamps:
(0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. April Armstrong, Vice President of Takeda, Dr. Benoît Guérette, and patient advocate Jensen, who discuss the unmet needs of people with moderate psoriasis and how as a community we can better serve those living with the disease.
2:22 How health care providers and the biopharmaceutical industry are coming together to address systemic eligibility and the unmet needs of people living with psoriasis.
4:25 Quality of life should be included when assessing clinical severity in psoriasis and identification of appropriate treatment choices.
6:52 The impact of misdiagnosis, inappropriate treatment, and effect on high impact sites can be life- altering.
8:30 How appropriate treatment and knowledge can make all the difference when diagnosed with plaque psoriasis.
9:40 Views on the psoriasis disease classification system and how it's evolving to include real life impact from physical and emotional needs, to more personalized care for those living with psoriasis, even when small body surface areas are involved. Severity isn't defined by skin coverage alone.
12:38 What's needed to prioritize the care and outcomes of people living with psoriasis.
14:18 The future of management and care for psoriatic disease.
15:53 "My skin tells a story." Wisdom from what I wish I had known previously.
16:52 Moving closer to care that truly reflects the lives and needs of those who live with psoriasis.
Key Takeaways:
· Severity of psoriasis isn't defined by skin coverage or body surface area (BSA) alone. The impact on quality of life should also be considered in the assessment, selection of treatment, and management of the disease.
· The psoriasis disease classification system is evolving to be more of a patient centered approach. Many clinicians are now using the International Psoriasis Council (IPC) or 2 bucket approach to identify whether someone should receive a topical or systemic treatment based on location and response to treatment, as well as impact on quality of life.
· With continued research and development, the next 5 to 10 years could see a shift in effective treatment options while also treating sooner to initiate better outcomes for people living with psoriasis and psoriatic arthritis.
Guest Bios:
April Armstrong, M.D., M.P.H. is an internationally renowned dermatologist and clinical researcher who is a Professor and Chief of Dermatology at the University of California Los Angeles (UCLA) where she specializes in inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa (HS). Dr. Armstrong is also the Co-Director for Network Resources at the UCLA Clinical and Translational Research Institute. She has conducted over 150 clinical trials and published over 350 high impact articles in scientific journals. Dr. Armstrong holds multiple leadership positions including the immediate Past Chair of the National Psoriasis Foundation Medical Board, Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Psoriasis Council, and board member for the International Dermatology Outcome Measures and the American Academy of Dermatology.
Benoît Guérette, Ph.D. is an accomplished leader in medical affairs with extensive experience across academia and the pharmaceutical industry. Since March 2025, Dr. Guérette has served as Vice President of Dermatology and Rheumatology US Medical Affairs at Takeda Pharmaceutical. Prior to joining Takeda, he held several strategic and leadership roles at various pharmaceutical companies, including overseeing clinical development, global and U.S. medical affairs, global access & pricing, translational sciences and more. Before transitioning to the industry, Dr. Guérette was an Associate Professor of Immunology at Laval University, leading research in cancer immunology. He holds a Ph.D. in Medicine, Microbiology, and Immunology from Laval University and completed postdoctoral studies in Inflammation and Immunology at Harvard Medical School.
Jensen is a volunteer and former Lead Youth Ambassador for the National Psoriasis Foundation. Jensen developed psoriasis at age 7 but wasn't formally diagnosed until age 14 being misdiagnosed along the way, trying different management approaches that were ineffective. She was a competitive swimmer from elementary through high school and in the last 2 years of high school played lacrosse. Upon finishing high school she attended college becoming a registered nurse in an intensive care unit. Jensen wants "youth living with psoriatic disease to feel a community that is behind them and with them every step of the way. I really want to be able to make a difference in a way that would've helped me as a child when I was diagnosed."
Resources:
Ø "Reassessing Psoriasis Severity" Advance Online, National Psoriasis Foundation. H. Onorati. January 16, 2024, https://www.psoriasis.org/advance/psoriasis-severity-high-impact-sites/
Ø "Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and Activities". Blauvelt, A., Strober, B., Gondo, G., Journal of Psoriasis and Psoriatic Arthritis Volume 8, Issue 3. https://journals.sagepub.com/doi/full/10.1177/24755303231160683
Description:
Chronic pain can be difficult to live with. If you have psoriatic arthritis you know all too well what that means. Listen as physiatrist Dr. Erin Maslowski and LB Herbert offer ways to manage pain before it manages your life.
Join host Susan McClelland-Tobert, a retired pediatric cardiologist who also lives with psoriatic disease as she uncovers the topic of what is chronic pain and how to manage it with Dr. Erin Maslowski, a physiatrist at Emplify Health System who specializes in physical medicine, rehabilitation and pain management, along with LB Herbert who also lives with psoriasis and psoriatic arthritis, and knows all too well what it means to live with pain, developing her own pain tool kit. Hear different strategies for managing initial flares to when pain escalates. Pain doesn't have to dictate how you live your life.
This episode addresses why pain occurs, it's impact, and what can be done to manage pain both physically and emotionally.
Timestamps:
(0:23) Intro to Psoriasis Uncovered & guests physiatrist Dr. Erin Maslowski and LB Herbert
(1:48) The unpredictability of pain and what pain means to LB.
(2:31) The science behind what happens in the body when acute and chronic pain occurs.
(5:08) General principles and first steps to managing pain associated with inflammatory arthritis.
(11:00) Recognition of flares and taking action to reduce the impact before pain escalates. .
(14:02) Steps to address the chronic pain cycle as it escalates such as steroid injections and medications that change how the brain perceives pain signals.
(20:54) Side effects and cautions for use of pain management medications.
(24:17) What and who LB turns to for managing her pain.
(25:50) Support resources and who to consider as part of a pain management team.
(33:16) Overcoming the stigma of mental health and "it's all in your head".
(34:45) Addressing the challenge of fatigue that often comes with pain. It's more than feeling tired.
(39:32) Activities to keep the body moving to help avoid stiff joints. .
(42:11) What's on the horizon for managing pain.
(44:55) Start small, experiment with change, but above all give yourself grace if you're not able to do something. Gain what control you can to live your life your way.
Key Takeaways:
· Chronic pain (existing for more than 3 months) occurs when ongoing inflammation keeps signaling pain via the nervous system becoming hypersensitized and greater than the original pain signal. This can occur even when inflammation is managed and in control.
· Treating chronic pain is complicated however there are many different avenues to help minimize pain associated with inflammatory diseases such as psoriatic arthritis.
· Management of chronic pain involves a variety of specialists and support to help address the physical and emotional impact of living with chronic pain.
Guest Bios:
Dr. Erin Maslowski is a board-certified physician, physiatrist, at Emplify Health System where she specializes in Physical Medicine, Rehabilitation, and Orthopedic Sports Medicine providing care for musculoskeletal and spine injuries and pain management including image-guided injection procedures. She has expertise in treating arthritis, spinal stenosis and spondylosis, rotator cuff injury, and other conditions with the ultimate goal of restoring function after injury to the muscle, bone, soft tissue, or nervous system. Dr. Maslowski is a Clinical Assistant Professor at the University of Wisconsin School of Medicine and Public Health where she teaches both medical students and residents. She has over 15 years of clinical experience in physical medicine and rehabilitation.
LB Herbert, has been living with the challenge of managing pain associated with psoriatic arthritis for 16 years, even developing her own tool kit through the years. She has shared what's she's learned on other episodes of this podcast, through articles, and as a One-to-One Program mentor for the National Psoriasis Foundation. LB began her journey in 2009 with back pain. Following many years of being misdiagnosed she finally found a rheumatologist who put all her symptoms together to diagnose her with psoriatic arthritis and place her on an appropriate treatment path. She states "my biggest challenge is not knowing what each day will bring, what the symptoms will be, and if I wake up and flare. It's a continuous unknown."
Resources:
- Chronic Pain kit
- NSAIDS for Psoriatic Disease
- Podcast episode: "Living with Chronic with Chronic Pain and Fatigue in PsA and SpA" with rheumatologist Dr. Philip Mease, Dr. Ernest Choy, from Cardiff University School of Medicine, with patients Melissa Leeolou and Minionette "Mini" Wilson who discuss causes, symptoms, risks, and tips for managing chronic pain and fatigue successfully.
Description:
In this episode, we'll explore what it means to aim for no compromise in psoriatic arthritis care—addressing both skin and joint symptoms with dermatologist and rheumatologist Dr. Saakshi Khattri and patient advocate Dayna Pham who lives with psoriasis and psoriatic arthritis.
Join moderator Jeff Brown as he asks how patients and their healthcare providers can work in partnership to create a comprehensive, personalized treatment plan that reflects the full impact of psoriatic disease with triple board-certified dermatologist, rheumatologist, and internist Dr Saakshi Khattri, who is also an NPF medical board member, along with Dayna Pham, a patient advocate and volunteer with NPF's advocacy and community engagement teams who is living with psoriasis and psoriatic arthritis. . Whether you're newly diagnosed or navigating long-term care, this conversation is all about advocating for care that supports your whole self—without settling for less.
The intent of this episode is to emphasize the need to be aware of psoriatic arthritis symptoms and once symptoms are present accept no compromise when treating skin and joints to obtain clear skin and painless joints.
This podcast episode is sponsored by UCB.
Timestamps:
(0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist, rheumatologist, and internist Dr. Saakshi Khattri and Dayna Pham, a patient advocate and medical student living with plaque psoriasis and psoriatic arthritis.
(1:38) Psoriasis is more than skin deep with an inflammatory connection between the skin and joints.
(3:03) The onset of psoriatic arthritis can be confusing. Healthy skin and joints should be the expectation without having to compromise on life's goals.
(4:16) Knowing the association between psoriasis and psoriatic arthritis from the beginning is important to avoid delay in diagnosis and treatment. Be aware of systemic symptoms and discuss risks with a health care provider.
(6:18 ) The goal of treatment is to achieve meaningful and lasting improvement in skin and joint symptoms.
(7:56) Treatments have evolved to target known drivers of inflammation in psoriasis and psoriatic arthritis.
(8:29) The IL-17 family is a key cytokine with 6 related signaling molecules. IL-17A and F play a role in the inflammatory process related to psoriasis and psoriatic arthritis.
(9:48) What discussion about treatment goals could include between a patient and health care provider.
(13:19) If you have psoriasis and psoriatic arthritis you should feel empowered to speak up, seek answers, and find a treatment that offers no compromise on achieving clear skin and healthy joints.
Key Takeaways:
· Psoriasis is an immune mediated disease that results in systemic inflammation that can affect both the skin and joints. Unfortunately many people do not realize their joint symptoms may be related to their psoriasis.
· The purpose of treatment which uses a variety of mechanisms of action targeting specific cytokines such as TNF-alpha, IL-12/23, IL-23, IL-17 is to achieve meaningful and lasting improvement in skin and joint symptoms.
· If you have psoriasis and psoriatic arthritis you should feel empowered to speak up, seek answers, and to work with your health care team to identify goals and treatment choices that aim to preserve quality of life.
Guest Bios:
Saakshi Khattri, M.D., MAS, is a triple board certified medical dermatologist, rheumatologist, and internist in the greater New York area who serves on the medical board of the National Psoriasis Foundation. She is the Director of the Center for Connective Tissue Diseases at Icahn School of Medicine at Mount Sinai. Dr. Khattri's area of interests include inflammatory and autoimmune skin diseases especially those with a rheumatology/dermatology overlap like psoriasis and psoriatic arthritis. She is actively involved in research and clinical trials for psoriasis and psoriatic arthritis where she seeks to identify immune pathways that lead to new biomarkers and treatments. Dr. Khattri is extensively published in peer reviewed journals and is also a member of the International Psoriasis Council.
Dayna Pham is a patient advocate, medical student, and volunteer with NPF's advocacy and community engagement teams who lives with psoriasis and psoriatic arthritis. Dayna's psoriasis journey began at age 21 when she discovered bumps on her back which became plaques. Within weeks her body was impacted head to toe with plaque psoriasis, at 40% BSA. After being misdiagnosed and undertreated for a few months she eventually found a dermatologist who diagnosed her with moderate-to-severe plaque psoriasis and prescribed a biologic. She's 25 now and seeks to live her fullest life possible while balancing her psoriasis and psoriatic arthritis.
Resources:
· Learn more about psoriatic arthritis from symptoms, diagnosis, treatment options to
coping with the disease.
Ø · Armstrong A, Levit NA, Schneider B, et al. Patient-identified treatment goals for psoriatic disease: Results from a US patient survey. J Psoriasis Psoriatic Arthritis. 2025;10(1):1–11.
Description:
Listen as NPF Medical Board Members, dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman discuss the connections between psoriasis and psoriatic arthritis, from cytokines to triggers, current and future treatments.
Join moderator Alan Simmons as he gains insights on what connects psoriasis and psoriatic arthritis with leading experts in psoriatic disease and NPF Medical Board members, dermatologist Dr. Robert Kalb with Buffalo Medical Group Dermatology, and rheumatologist Dr. Sergio Schwartzman from Schwartzman Rheumatology, as they discuss the known drivers of psoriasis and psoriatic arthritis, common triggers, benefits of targeted treatments, remission of disease, and upcoming treatment trends.
The intent of this episode is to identify potential connections between psoriasis and psoriatic arthritis, and how targeted treatments have changed the outlook for management of psoriatic disease.
This episode is sponsored by Novartis.
Timestamps:
(0:41) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman who are both involved in clinical care and research of psoriasis and psoriatic arthritis.
(1:15) Current known pro-inflammatory cytokines and cells found in psoriasis and psoriatic arthritis.
(5:33) Types of psoriasis that may lead to a higher risk of developing psoriatic arthritis.
(9:33) Common triggers for psoriasis and psoriatic arthritis that could cause flares of the disease.
(12:59) Key factors that are considered when choosing a treatment plan for any individual with psoriatic arthritis and psoriasis.
(18:04) What treatment remission means for psoriasis.
(19:36) Use of minimal disease activity (MDA) in psoriatic arthritis and what it means.
(22:14) How a better understanding of the disease has led to more effective treatment choices and what choices are used by Dr. Kalb and Dr. Schwartzman for the management of psoriasis and psoriatic arthritis.
(28:39) New developments in treatment and research in psoriatic arthritis and psoriasis.
(36:01) Given treatment advancements it's a wonderful time to treat psoriatic disease.
3 Key Takeaways:
· Cytokines are chemicals in the body that moderate various processes. In psoriasis and psoriatic arthritis, an unknown trigger stimulates some cells to overproduce pro-inflammatory cytokines such as TNF-alpha, IL-17 or IL-23 leading to the development of skin and joint disease.
· Treating psoriasis and psoriatic arthritis helps move the body towards normalizing the over reactive immune system especially with more targeted treatments that safely and effectively block specific cytokines without affecting other organ systems.
· Given advancements in targeted treatments the goal is to reach and maintain remission of psoriatic disease.
Guest Bios:
Leading dermatologist Robert Kalb, M.D. is the Chair of the Buffalo Medical Group Dermatology Department and the Director of the Buffalo Medical Group Phototherapy Center, one of the leading centers for psoriasis care in Western New York. He is also a Clinical Professor of Dermatology at the State University of New York at Buffalo School of Medicine and Biomedical Sciences (SUNY Buffalo), as well as an Adjunct Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania where he plays a significant role in medical education, mentoring both medical students and dermatology residents. Dr. Kalb has extensive experience managing psoriasis, atopic dermatitis, and other inflammatory skin diseases. He has authored 70+ publications and is actively involved in clinical research, particularly focused on new treatment options for psoriasis. He is a member of the NPF Medical Board, American Academy of Dermatology, and is a member of the International Psoriasis Council.
Sergio Schwartzman, MD, is a world-renowned rheumatologist based in New York City who brings almost 40 years of experience and personalized clinical care for those who have psoriatic disease. Along with being in private practice at Schwartzman Rheumatology, Dr. Schwartzman is a Clinical Associate Professor of Medicine at Weill Cornell Medical College of Cornell University, the New York-Presbyterian Hospital, and the Hospital for Special Surgery in New York City where he has played a role in educating medical students, residents, fellows, and peers in rheumatology. Additionally, Dr. Schwartzman is the emeritus Franchellie M. Cadwell Clinical Associate Professor at the Hospital for Special Surgery. Dr. Schwartzman's current research interests include psoriatic arthritis, the spondyloarthritis group of diseases, ankylosing spondylitis, rheumatoid arthritis, as well as defining and treating autoimmune diseases of the eye. He has authored, co-authored, and edited over 150 papers, abstracts, books and book chapters on topics including psoriatic arthritis, ankylosing spondylitis, axial spondylarthritis, rheumatoid arthritis, lupus, autoimmune eye disorders, and other rheumatological and autoimmune conditions. He is a member of the NPF Medical Board. He is also a member of the American College of Rheumatology, the Association for Research in Vision and Ophthalmology, the Spondyloarthritis Research and Treatment Network (SPARTAN), the American Uveitis Society, and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Resources:
Ø "Redefining Remission. A new definition for patients, providers, and payers." Advance Online, National Psoriasis Foundation. S. Schlosser. July 14, 2025.
Ø Treatment and Management of Psoriasis
Ø Treatment and Management of Psoriatic Arthritis
Episode Description:
Not sure if you should receive a vaccine given your psoriasis or psoriatic arthritis medication? Dermatologist Dr. Jason Hawkes explores this question along with vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis.
Listen as hosts Jeff Brown and LB Herbert discuss key questions about vaccine use and psoriatic disease with dermatologist and NPF Medical Board member Dr. Jason Hawkes who is co-owner, Chief Scientific Officer, and investigator with the Oregon Medical Research Center. Hear what the difference is between live and non-live vaccines, how type of vaccine and immunosuppressive medications impact the timing of vaccines in relation to treatment half-lives. Get your questions answered.
The intent of this episode is to offer answers to questions about vaccine use for people with psoriasis and psoriatic arthritis who take immunosuppressive treatments.
Timestamps:
(0:23) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Jason Hawkes.
(1:15) In general, what is a vaccine and how it works in the body.
(2:08) Will vaccines provide the same level of protection in people with psoriatic disease who are on treatments that influence the immune system.
(4:53) The difference between live and non-live vaccines.
(8:57) Summary of NPF Vaccine Recommendations in relation to live and non-live vaccines and specific medications for psoriatic disease, including a definition of medication half-lives.
(13:38) Vaccines that may be recommended prior to starting a systemic medication or biologic.
(18:27) The mRNA vaccine – how it works in comparison to other vaccines.
(22:31) How long immunity lasts from childhood vaccines.
(25:24) The vaccine guidelines apply to both psoriasis and psoriatic arthritis with some nuances.
(28:38) Which healthcare provider to turn to for advice about vaccines and why.
(31:54) Questions to ask your health care provider about vaccines.
(33:26) How clinical trials and registries are evolving to assess the effect of vaccines with specific medications and the need for greater understanding.
(36:44) Develop a good relationship with your health care provider and don't be afraid to ask questions about your psoriatic disease, vaccines, or specific medications.
Key Takeaways:
· Vaccines work to help protect the body or stimulate protection against common infections or pathogens. There are different types that can be classified as either live or non-live vaccines.
· Evidence-based vaccine recommendations are available for people with psoriasis and psoriatic arthritis to help guide timing of when to receive live and non-live vaccines when taking immunosuppressive oral systemic medications and/or biologics.
· It's important to discuss which vaccines to consider, and how current psoriasis medication could impact the intended response and timing with your health care team which includes a primary care physician, a dermatologist, and/or rheumatologist.
Guest Bio:
Dermatologist Jason Hawkes, M.D., MS is Co-owner, Chief Scientific Officer and Investigator with Oregon Medical Research Center (OMRC) in Portland, Oregon. He is also a Clinical Assistant Professor of Dermatology at Oregon Health and Science University and the President and Sole Member of Hawkes Dermatology. Prior to joining the Oregon Medical Research Center, Dr. Hawkes held academic faculty appointments in the Departments of Dermatology at the University of Utah School of Medicine, Icahn School of Medicine at Mount Sinai, and University of California-Davis. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, chronic urticaria (hives), and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions. Dr. Hawkes is also a Councilor of the International Psoriasis Council (IPC) and serves on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF) where he participates in the development of clinical consensus statements.
Resources:
"Does Having Psoriatic Disease Impact Vaccine Choices?" Psound Bytes™ podcast with Dr. Sandy Chat (University of California) and Dr. Christoph Ellebrecht (Dept. of Dermatology, University of Pennsylvania).
Medical Board Clinical Statements
Episode Description:
Listen as Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, and Dermatologist, Dr. Jeffrey Cohen discuss the 2025 Medicare changes in relation to psoriatic disease and what’s to come in 2026 with Jason Harris, Vice President of Government Relations and Advocacy at NPF.
Join this discussion about what changes occurred with Medicare in 2025 that impact psoriatic disease care, outcomes to date, what’s to come in 2026, and what you should consider when choosing health care plans during open enrollment with Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, Dermatologist, Dr. Jeffrey Cohen, Director of the Psoriasis Treatment Program at Yale University School of Medicine, and Jason Harris, Vice President of Government Relations and Advocacy at NPF.
The intent of this episode is to increase knowledge of the 2025 Medicare changes, what’s to come, and how such changes impact psoriatic disease from coverage of prescriptions to overall health care.
This episode is sponsored by Novartis.
Timestamps:
(0:24) Intro to Psoriasis Uncovered and guest welcome Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, and Dermatologist, Dr. Jeffrey Cohen, Director of the Psoriasis Treatment Program at Yale School of Medicine.
(2:25) Perspectives on current health care coverage in Medicare.
(5:14) Biggest changes to Medicare in 2025.
(6:36) What is the Medicare Prescription Payment Plan and price negotiation for specific medications.
(8:22) Challenges associated with the 2025 Medicare changes from a physician’s perspective.
(13:10) Price negotiation process via CMS (Centers for Medicare and Medicaid Services) with the first 10 drugs price effective in 2026.
(17:52) Plan ahead and what to anticipate when choosing the right Medicare plan.
(20:04) What the National Health Council and other patient advocacy organizations are doing to assess the impact of the CMS changes and identify steps for moving forward.
(21:49) Medicare changes for 2026 that affect deductibles for health care services, prescription drug coverage, and vaccinations.
(28:38) Potential assistance options for people who have Medicare insurance.
(31:32) The role of patients in providing feedback on policy changes.
(33:45) Changing from a commercial insurance plan to a Medicare Plan and what to think about when viewing plan options during the open enrollment period.
(37:07) Be part of the process – let your voice be heard by sharing your experiences to help effect change.
3 Key Takeaways:
· There are four key parts to Medicare health insurance (Part A, B, C and D) which underwent changes in 2025 including a payment cap for prescriptions and availability of a 12 month Prescription Payment Plan to opt in for medications. Additional changes are coming in 2026 including enactment of a price negotiated list of 10 medications.
· The impact of such changes are both positive (better predictability and affordability) yet also reactionary. Such changes and potential impact should be considered when identifying plan coverage for health care and prescriptions during the open enrollment Medicare period of October 15 to December 7th.
· Be involved by telling your story about the impact of Medicare changes and find a trusted health care provider who is willing to work with you to identify an effective treatment plan that aligns with your health care needs and coverage.
Guest Bios:
Dermatologist Jeffrey Cohen, M.D., MPH, is the Director of the Psoriasis Treatment Program and the Director of Safety with the Department of Dermatology at Yale University School of Medicine where he is also an Associate Professor of Dermatology and Biomedical Informatics and Data Science. Dr. Cohen treats a variety of skin conditions with a special interest in diseases of the immune system such as psoriasis and eczema tailoring treatments for each individual. He is the author of over 150 peer-reviewed articles on psoriasis and other topics in dermatology. Dr. Cohen serves on the Editorial Board of the Journal of the American Academy of Dermatology, is a Senior Editor for NPF’s professional journal for health care providers Journal of Psoriasis and Psoriatic Arthritis, is a Councilor of the International Psoriasis Council, and serves on the Medical Board of the National Psoriasis Foundation.
Kimberly (Kim) Beer is Senior Vice President of Policy and External Affairs at the National Health Council (NHC) of which the National Psoriasis Foundation is a member. Kim leads strategic policy initiative and advocacy efforts to improve the lives of individuals with chronic conditions and disabilities. As a member of the NHC’s executive leadership team, she helps to ensure access to high-quality, affordable healthcare for all Americans which includes advocating for policy and health care benefits within Medicare.
Resources:
For more reources and information about Medicare
Contact the Patient Navigation Center to learn more about Medicare, find a health care provider, learn about treatments, or programs that may lower costs.
Dermatologist Dr. Erin Boh and patient advocate Brian Lehrschall discuss the challenge of managing weight, psoriasis, and psoriatic arthritis which share common inflammatory pathways and what can be done to improve all together.
Join moderator Jennifer Bomberger as she asks what is the connection between psoriatic disease and excess weight and what can be done to counter the effects of inflammatory cytokines for both with leading dermatologist Dr. Erin Boh and Brian Lehrschall who has lost over 100 pounds using diet, exercise and a GLP-1 receptor agonist. Hear Brian’s story along with what is a GLP-1, how they work, and side effects.
The intent of this episode is to offer knowledge and an example of how a GLP-1 can be used successfully to improve the outcomes and management of psoriasis and psoriatic arthritis.
This episode is sponsored by Lilly.
A Word of Warning
This episode contains information about the body, like body size, weight management, healthy eating, and lifestyle changes. If you have a history of disordered eating or are struggling with body-related mental health challenges, you might wish to explore some of our other helpful tools.
There are clinical terms used by our speakers about body size or body weight that you might find triggering. Key among them is the word ‘obesity.’ While it is the scientifically correct name for a disease and a common clinical term, NPF acknowledges that this word is triggering and problematic, and it is used only for the clearest of accuracy.
Timestamps:
(0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Erin Boh and Brian Lehrschall, who has been living with psoriatic disease for over 30 years and has recently lost over 100 pounds.
(1:32) Health challenges Brian faced while trying to manage his weight, psoriasis, and psoriatic arthritis.
(4:08) Many factors contribute to psoriasis, psoriatic arthritis, and comorbidities.
(5:56) Discussing the sensitive subject of losing weight and changing lifestyle.
(7:57) The inflammatory pathways and connection between excess weight and psoriatic disease.
(14:50) Tips for managing multiple diseases like psoriatic disease, depression, and excess weight together. Realize “it’s not your fault”.
(21:32) Are low calorie or anti-inflammatory diets effective with psoriasis?
(25:21) The definition of a GLP-1 (receptor agonist), how they work, and benefits in resetting how the body functions.
(30:02) Brian’s experience and impact of using a GLP-1.
(32:08) Current and future use of GLP-1 in the management of psoriatic disease, comorbidities, and excess weight.
(34:49) Be an advocate for yourself to help do all the things that will make you feel better about living with psoriasis and psoriatic arthritis.
Key Takeaways:
· Obesity or excess weight is a disease driven by an overproduction of inflammatory cytokines.
· Psoriasis, psoriatic arthritis, and excess weight have shared pro-inflammatory disease pathways that should be considered together when identifying an effective treatment plan.
· GLP-1 receptor agonists can be used along with dietary changes and exercise to induce weight loss that improves the body’s reaction to medications used to treat psoriasis and psoriatic arthritis.
Guest Bios:
Erin Boh, M.D., Ph.D. is the Joseph Chastain Endowed Chair of Clinical Dermatology at Tulane University, School of Medicine where she is also a Professor and Chairman of Dermatology. Her clinical and research focus includes photobiology, chronic diseases such as psoriasis, psoriatic arthritis, and skin cancers such as lymphoma. Dr. Boh is a past Medical Board member of the National Psoriasis Foundation and is currently a President’s Council Member which represents an elite group of health care providers who are committed to the mission of the Foundation and finding a cure for psoriasis. Dr. Boh has published many articles including addressing today’s topic about weight management and inflammation in psoriasis.
Brian Lehrschall has lived with psoriatic disease for three decades. He was first diagnosed with psoriasis about thirty years ago, at the age of 13 and with psoriatic arthritis at age 15. With the diagnosis came bullying which led to emotional eating. Per Brian “The more I ate, the worse the weight got.” Like most people who are overweight Brian tried to improve his health with diet and exercise. Along the way he learned about the connection between psoriasis and excess body weight. Eventually a physician recommended he try the weight loss medication GLP-1 (Glucagon-like peptide-1). Using this medication he has lost over 100 pounds and is still losing weight along with improving his overall health which includes his psoriasis and psoriatic arthritis. Brian joined the National Psoriasis Foundation in 2000 as a volunteer and has become an advocate for improving access to care and sharing his story about living with psoriatic disease.
Resources:
Ø “Taking Back Control” Advance Online. M. Werbach. July 17,2025.
Ø “Is Choosing the Mediterranean Diet Right For You and Your Psoriatic Disease?” podcast episode with dermatologist Dr. Adam Ford and registered dietitian, Danielle Baham.
Ø Find the support you need through the One to One Program
Leading dermatologist and NPF Medical Board Member, Dr. Tina Bhutani, and Gail Reiser who lives with plaque psoriasis discuss what “on treatment remission” means for those who have the disease and health care providers.
Join moderator and resident physician Olivia Kam as she discusses the definition of on treatment remission for plaque psoriasis, and how this definition impacts the management of the disease and when to change treatments with leading dermatologist Dr. Tina Bhutani from Synergy Dermatology in San Francisco, and Gail Reiser who has been living with plaque psoriasis for over 42 years experiencing a variety of treatment options.
The intent of this episode is to increase knowledge of the latest consensus statement defining what “on treatment remission” means in the context of managing plaque psoriasis and how such information can be used to guide patient/provider discussion and setting treatment goals.
This episode is sponsored by AbbVie.
Timestamps:
(0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Tina Bhutani and Gail, who has been living with plaque psoriasis for over 42 years.
(1:56) Definition of “on treatment remission” and development of this unified consensus statement that included almost 100 stakeholders.
(3:28) How the definition of “on treatment remission” impacts management of psoriasis.
(5:09) A patient’s perspective about “on treatment remission” and what it means for future care.
(8:57) Assessing when a change in treatment may be appropriate.
(11:19) What information a dermatologist can provide to assess if treatment is effective.
(14:20) Prioritizing what to discuss with a dermatologist or health care provider.
(17:21) Call to action for dermatologists from the “On Treatment Remission” consensus statement.
(20:37) Advice for discussing treatment goals as a patient and health care provider.
Key Takeaways:
· A new consensus statement helps define and standardize what “On Treatment Remission” is and what it means for patient care.
· Given current treatment options it is possible to reach skin clearance and on treatment remission.
· Having standardized goals makes it easier for health care providers and patients who have psoriatic disease to work together to reach on treatment remission.
Guest Bios:
Tina Bhutani, M.D., MAS, is a board-certified dermatologist who is the CEO and owner of Synergy Dermatology in San Francisco. Dr. Bhutani is also an Associate Clinical Professor of Dermatology at UCSF where she previously co-directed the Psoriasis and Skin Treatment Center and directed the Clinical Trials Unit for over 8 years. Dr. Bhutani understands the importance of treating the whole patient and is committed to a patient-centered approach to dermatology. She is a recognized leader in dermatology, giving talks at many national and international meetings. Dr. Bhutani is a member of the National Psoriasis Foundation Medical Board who recently published a consensus statement called “Defining On Treatment Remission in Plaque Psoriasis” in JAMA Dermatology.
Gail Reiser was initially diagnosed with plaque psoriasis at age 12. She remembers the misdiagnoses and difficult treatments of the past such as coal tar and occlusion. Over 42 years of living with plaque psoriasis, Gail has experienced a variety of treatment options including topicals and light therapy, feeling “it is exhausting to treat psoriasis”. As she got older and her plaque psoriasis progressed, she eventually decided to try biologics and hasn’t looked back since making that change. She feels her psoriasis is in remission but fears losing that in the future.
Resources:
- “Redefining Remission. A new definition for patients, providers, and payers.” Advance Online, National Psoriasis Foundation. S. Schlosser. July 14, 2025.
- To hear other perspectives about living with psoriasis through the resource Gail mentioned: MyPsoriasisTeam.
- Treatment and Management of Psoriasis
Pediatric rheumatologist Dr. Pamela Weiss speaks with Michael and his 12 year old daughter Ava about navigating the challenge of living with psoriasis and psoriatic arthritis together as a family.
Join moderator Kaleigh Welch as she discusses the challenges of living with psoriasis and juvenile psoriatic arthritis (JPsA) from diagnosis, misconceptions about psoriatic disease, to management and treatment with pediatric rheumatologist, Dr. Pamela Weiss from Children's Hospital of Philadelphia, Division of Rheumatology, along with Michael and Ava, whose psoriatic disease is truly a family affair.
The intent of this episode is to raise awareness about the complexities and nuances associated with living with psoriasis and psoriatic arthritis as a child or an adult and not letting the disease stop you from doing what you love to do.
This episode is sponsored by Amgen. Mike, Ava, and Dr. Weiss were compensated for their time.
Timestamps:
· (0:00) Intro to Psoriasis Uncovered and guest welcome pediatric rheumatologist Dr. Pamela Weiss, Michael and Ava Sayles who both have been diagnosed with psoriasis and psoriatic arthritis.
· (1:28) What the psoriatic disease diagnosis process could be like for children and adults.
· (5:34) Misconceptions associated with psoriasis leading to delayed diagnosis of psoriatic arthritis.
· (7:36) What people misunderstand about plaque psoriasis and psoriatic arthritis.
· (11:06) Challenges to finding the right treatment while living life with psoriatic disease.
· (17:24) What drives treatment choices for psoriatic disease in youth.
· (19:59) Assessing what’s most important in reaching treatment goals.
· (23:57) What the future holds for management of Juvenile Psoriatic Arthritis (JPsA).
· (26:10) Living with psoriatic disease is challenging but find what’s right for you and don’t give up on what you love to do.
Key Takeaways:
· Diagnosis of plaque psoriasis and psoriatic arthritis can be challenging given subtleties that can occur in the presentation of the disease in adults and children.
· There are a variety of treatments that work either alone or in combination to treat plaque psoriasis and psoriatic arthritis with choice of treatment dependent on what is the primary goal for the individual’s physical and emotional health.
· The future is bright as understanding of the disease increases and treatment options expand and become more targeted to more effectively address skin and joint issues associated with psoriatic disease.
Guest Bios:
Pamela Weiss, M.D., MSCE, is a pediatric rheumatologist and the Clinical Research Director of the Division of Rheumatology at Children's Hospital of Philadelphia. Dr. Weiss is also the Distinguished Endowed Chair in the Department of Pediatrics. She has advanced training in clinical epidemiology with a focus on early diagnosis, and targeted treatment of children with spondyloarthritis (SpA). Dr. Weiss is also a Professor of Pediatrics and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania. She is a member of the American Academy of Pediatrics, American College of Rheumatology, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the Spondylitis Association of America, and the SPondyloArthritis Research & Treatment Network (SPARTAN).
Michael and Ava Sayles, psoriatic disease is a family affair. Both father and daughter, successfully navigate living with plaque psoriasis and psoriatic arthritis. Michael or Mike was diagnosed in his twenties, and Ava at age 7 and then later on juvenile psoriatic arthritis. She is now 12 years old. They have experienced issues with diagnosis, and a long journey of finding treatment options that worked for them. Mike found the best solution was establishing a routine or rhythm of treatment around work and school to avoid flare-up’s if possible, saying “keeping on top of what you need to do for the psoriasis and the arthritis becomes a big part of your life".
Resources:
Our Spot: What is Psoriatic Arthritis
Is it scalp psoriasis or something else? If it is scalp psoriasis what do I do about it? These questions and more are answered by leading dermatologist Dr. Ronald Prussick as we uncover what is scalp psoriasis.
Join host Corinne Rutkowski as she talks with dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD about scalp psoriasis compared to dandruff, seborrheic dermatitis or eczema, and how characteristics may differ, along with what treatments and actions are effective to address scalp psoriasis.
This episode offers helpful insights and tips to address symptoms and care of scalp psoriasis.
Timestamps:
· (0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick.
· (1:19) What is dandruff and key characteristics.
· (2:28) Treatments for dandruff.
· (3:28) What is seborrheic dermatitis and characteristics.
· (4:18) Treatment options for seborrheic dermatitis.
· (7:04) How scalp psoriasis compares to dandruff, seborrheic dermatitis or eczema, and what are the key differences.
· (9:24) Why scalp psoriasis is a high impact site and how itching of the scalp leads to Koebnerization.
· (12:46) Prescription and over the counter treatment options for scalp psoriasis.
· (18:11) Tips for using shampoos and applying treatments on the scalp.
· (24:08) Hair loss or alopecia with scalp psoriasis.
· (25:22) Upcoming treatments for scalp psoriasis.
· (27:38) Most important point to know about scalp psoriasis.
Key Takeaways:
· Some skin diseases may be confused with scalp psoriasis, however psoriasis does have key characteristics which helps lead to a definitive diagnosis.
· Scalp psoriasis is a high impact area meaning body surface area (BSA) is less than 10% however impact on quality of life is significant and is a factor in determining choice of treatment(s) whether prescription or over the counter.
· Be aware of the risks for Koebnerization of the scalp and take precautions to minimize itching and scratching through application of treatments and care of the scalp.
Guest Bio:
Leading dermatologist Ronald Prussick, M.D., is Vice Chair of the Medical Board for the National Psoriasis Foundation and the Medical Director of Washington Dermatology Center in Rockville and Frederick, MD where he specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails using the latest technology and products. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, DC. He has been published many times and frequently speaks at medical conferences across the country and internationally including providing podcast episodes, such as on Psound Bytes addressing facts about nutrition and psoriasis in episode #196 “Facts About Nutrition, Diets and Psoriatic Disease”. Dr. Prussick has been voted one of the top doctors by the Washingtonian Magazine time after time and has been repeatedly named one of America’s Top Physicians by the Consumers Research Council.
Resources:
Ø Medicated Psoriasis Shampoos Your Scalp Will Love
Ø To find a dermatologist if needed: Patient Navigation Center
Ø NPF Seal of Recognition Product Directory
Hear Christopher McKim’s journey with moderate to severe plaque psoriasis and the latest clinical trial results from dermatologist, Dr. Christine Cornejo.
Join this discussion with moderator Archie Franklin as Christopher McKim, a BMS employee living with moderate to severe plaque psoriasis, and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at BMS, offer a patient and physician’s perspective on treating plaque psoriasis from the inside. Listen as Chris presents his journey along with Dr. Cornejo addressing effectiveness and safety information with clinical trial results for a prescription oral treatment option.
The intent of this episode is to encourage those who have moderate to severe plaque psoriasis to work with their health care provider to find a treatment option that is right for them.
This episode is sponsored by Bristol Myers Squibb. For more information view Full Prescribing Information and Medication Guide .
· (0:00) Intro to Psoriasis Uncovered and guest welcome to Bristol Myers Squibb employee and patient Christopher McKim and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at Bristol Myers Squibb.
· (2:15) Where the journey to finding the right treatment option for Chris and his moderate to severe plaque psoriasis began.
· (3:09) The decision by Chris and his provider to try an oral systemic medication.
· (3:28) The effects and impact of an oral systemic treatment for Chris and his plaque psoriasis.
· (4:09) Dr. Cornejo addresses efficacy and clinical trials results.
· (5:58) Common side effects and safety concerns for the treatment Chris and his health care provider decided to try.
· (6:28) Health considerations patients and providers should discuss prior to using a systemic treatment.
· (6:54) What to do should side effects occur.
· (7:10) How Chris feels with clearer skin after making a change in treatment.
· (8:14) Indication and Important Safety Information.
Key Takeaways:
· Moderate to severe plaque psoriasis is a systemic disease.
· If you’re ready to treat from the inside there is a treatment option that may help.
· Work with a health care provider to find the right treatment for moderate to severe plaque psoriasis.
· Be proactive by taking steps to learn about treatment options including effectiveness, side effects, safety concerns, and what should be discussed with a health care provider before beginning a new treatment for plaque psoriasis.
Guest Bios:
Christopher (Chris) McKim joined BMS in June of 2022. In his current role he is a Regional Marketer for the dermatology division, prior to that he provided support for 9 Therapeutic Area Specialists for the Pacific South District in the GI division. Prior to joining BMS, Chris worked at Sanofi, J&J, Leo Pharma, and Sun Pharma in various field and home office roles.
Chris resides in beautiful San Diego with his family Susan (wife), Morgan 18, Maddy 16, Mason 14 and two Golden Retrievers and enjoys traveling, cooking and anything associated with the ocean (Deep Sea Fishing, S.C.U.B.A. diving, snorkeling, and boogie boarding).
Dr. Christine Cornejo joined Bristol Myers Squibb in 2024 as Director, Medical Engagement Lead for Dermatology and Rheumatology. Prior to joining BMS, she practiced dermatology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, MA, where she specialized in melanoma and high-risk skin cancer management and served as the Director of Confocal Microscopy. She also served as an Instructor at Harvard Medical School and led the Immunology and Infectious Diseases course for 1st year medical students.
Resources:
Current Oral Systemic Treatments
For additional questions about treatment options contact the NPF Patient Navigation Center
Feeling adventurous but not sure how to travel with your psoriasis and psoriatic arthritis? Listen as certified physician assistant Rosemary Son offers tips to help make your care easier while traveling near or far.
Join hosts LB Herbert and Kaitlin Walden as they talk tips for making travel easier whether in the US or abroad with certified Physician Assistant Rosemary Son from UT Southwestern Medical Center. Listen in as they discuss what to pack, keeping medications including biologics cool, where to find help if needed, tips for navigating airline travel, vaccines for traveling abroad, managing travel stress, infection precautions, and more.
This episode offers information to help you prepare in advance for that trip of a lifetime while maintaining management of your psoriasis and psoriatic arthritis so you can feel free to live your life to its fullest.
Timestamps:
· (0:00) Intro to Psoriasis Uncovered & guest welcome certified Physician Assistant Rosemary Son.
· (2:43) Tips for keeping medications (including biologics) cool when traveling in hot weather.
· (5:37) Types of skin and pain management products to pack.
· (8:41) Where to find help for psoriatic disease if needed in unfamiliar places.
· (10:43) Preparing for airline travel including liquid limitations and developing a “psoriasis passport”.
· (14:33) Travel to other countries and how to find over-the-counter medications if needed.
· (16:43) Vaccine recommendations for out of the country travel.
· (19:02) Cold weather protection recommendations.
· (21:27) Precautions for reducing risk of infection and should you purchase travel insurance.
· (24:17) Tips for managing stress as a disease trigger while traveling.
· (28:56) What to avoid when traveling.
· (31:36) Live life to the fullest with psoriatic disease and enjoy the adventure travel offers.
3 Key Takeaways:
· Managing psoriasis and psoriatic arthritis while traveling near or far is possible with advance preparation and use of precautions to help avoid stress associated with travel in changing environments.
· What and how you pack is key to reducing potential health issues that occur while traveling.
· A “psoriasis passport” or letter from your physician and a list of generic names for your medications can make travel in and out of the country easier.
Guest Bio:
Rosemary Son, M.P.A.S., PA-C, RDN is a board-certified physician assistant in the Department of Dermatology at the University of Texas (UT) Southwestern Medical Center and Parkland Health and Hospital System. As a dual-certified Physician Assistant and Registered Dietitian with over a decade of experience in dermatology, Rosemary has a passion for treating complex inflammatory skin diseases such as psoriasis, atopic dermatitis, hidradenitis suppurativa, as well as, treating diseases that impact skin of color, and identifying social determinants of dermatologic health. She also has a personal passion for travel. Ms. Son is a Director at Large and member of the Society of Dermatology Physician Assistants and the American Academy of Physician Associates serving as a liaison to the American Academy of Dermatology.
Resources:
Ø Taking Care of Your Skin in the Summer
Ø Patient Navigation Center
Join us to hear Jennifer's incredible unexpected journey from mysterious, itchy skin blotches leading to a full psoriasis diagnosis and how she found the right treatment for her with dermatologist Dr. Christina Feser and Mind.Px.
Listen as Jennifer tells her diagnostic odyssey from itchy, skin blotches to psoriasis with host Max Blitstein as together they explore her journey from topical treatments to biologics, and the emotional toll this disease can take. Learn how this psoriasis patient found relief with Dr. Christina Feser through the use of new precision medicine technology to find the right treatment for her.
This episode highlights the importance of proactive care and the life-changing impact of finding the right medical support.
Timestamps:
· (0:00) Intro to Psound Bytes™ and guest welcome dermatologist Dr. Christina Feser and her patient Jennifer Kirsch.
· (1:26) Jennifer’s life prior to her diagnosis journey with psoriasis.
· (2:29) Symptoms, diagnosis, and initial treatment course.
· (4:26) The path to taking control of Jennifer’s psoriasis begins with a Mind.Px test.
· (9:15) Timeline for the Mind.Px test results and how it felt to get the test.
· (12:14) Implementation and results of the treatment recommended by Dr. Feser and the Mind.Px test.
· (17:22) The emotional impact of living with psoriasis.
· (19:24) Be proactive when something is not right. Listen to your body.
· (19:57) Getting on the right medicine initially has value.
· (21:16) While the journey is not easy, taking advantage of available technology offers better management of patients with psoriasis.
3 Key Takeaways:
· Diagnosis of psoriasis can be challenging but it all starts with finding the right health care provider who listens to you as a patient.
· Technology now exists through Mind.Px to help providers and patients select a therapy that is more biologically appropriate to manage their psoriasis.
· Be proactive in taking steps to ensure you receive the right treatment for you and your health.
Guest Bios:
Dr. Christina Feser is a board-certified dermatologist with Nashville Skin, a comprehensive dermatology center for adults and children where she specializes in the latest medical treatments for skin diseases such as psoriasis that impact the skin, scalp, hair, and nails. She has a passion for research, serving as Principal Investigator on numerous clinical trials with a focus on psoriasis, eczema, alopecia, vitiligo, and other skin diseases. She is a fellow of the American Academy of Dermatology, the American Osteopathic College of Dermatology, and is a member of the Nashville Dermatology Society and the Tennessee Dermatology Society.
Jennifer Kirsch, a patient of Dr. Feser’s, was diagnosed with psoriasis in November 2024 after initially being diagnosed with eczema. Taking matters into her own hands, Jennifer not only found the right care with Dr. Feser, but also the right treatment to help her live her life without the itch associated with psoriasis.
Resources:
Ø Current Biologics on the Market https://www.psoriasis.org/current-biologics-on-the-market/
Ø Mindera Health – Shaping the Era of Digital Predictive Skin Analytics https://minderahealth.com
Having Generalized Pustular Psoriasis (GPP) can steam roll your life. Hear how dermatologist Dr. Oanh Lauring and patient advocate Jordan Hicks overcame the challenge of recognition to treating this rare form of psoriasis.
GPP is far more than just psoriasis. Recognition of this form of psoriasis with a unique cytokine presents challenges when symptoms are not so apparent and confusing. Join host Alan Simmons as he dives into the diagnosis journey, and treatment from acute to chronic flares with dermatologist Dr. Oanh Lauring, and what it means to live and stand up for yourself with GPP with Jordan Hicks.
This episode offers a heartfelt look at life with generalized pustular psoriasis (GPP) and the value of standing up for your health. Join GPP Awareness Day in August.
Timestamps:
· (0:00) Intro to Psound Bytes & guest welcome dermatologist Dr. Oanh Lauring and patient advocate Jordan Hicks.
· (1:08) Jordan’s diagnosis journey with generalized pustular psoriasis (GPP).
· (2:37) What is generalized pustular psoriasis and Dr. Lauring’s first encounter with GPP.
· (8:00) How GPP is different from plaque psoriasis but they can coexist together.
· (9:53) Treatment of acute GPP flares vs ongoing flare management.
· (12:29) The impact of GPP on Jordan’s life.
· (13:22) How to support those who live with GPP in the clinic setting and their mental health.
· (15:24) Tips for working with other specialists in management of GPP.
· (17:30) Feelings associated with being diagnosed with GPP.
· (20:43) Being a self-advocate is important to your healthcare journey.
· (22:18) If you have GPP, you are not alone. Initiation of GPP Awareness Day.
4 Key Takeaways:
· Diagnosis of generalized pustular psoriasis can take time given its confusing presentation in the early stages but can shift rapidly to urgent care when in the acute phase of the disease.
· Generalized pustular psoriasis and plaque psoriasis are distinct forms but can coexist together. 50% of patients with GPP also have plaque psoriasis.
· The impact of living with GPP is significant and finding support from those who understand, including health care providers, is critical to treating and coping with the disease.
· If you have GPP be a strong advocate for your health and your self-worth. Your symptoms are valid and you deserve to be heard.
Guest Bios:
Dr. Oanh Lauring is a board-certified dermatologist in private practice at Lauring Dermatology where she provides the utmost care and expertise for patients with serious skin diseases such as psoriasis that impact the skin, scalp, hair, and nails. She offers a variety of the latest medical treatments including generalized pustular psoriasis to help her patients achieve a natural and refreshed appearance.
Jordan Hicks took her health into her own hands. She moved from a small Texas town to Las Vegas in order to obtain care for her generalized pustular psoriasis or GPP. Once there she found her community and learned to speak up for herself and others. Jordan and her dog have been active advocates for GPP and Psoriasis ever since.
Resources:
Ø Find Support through GPP Circles and others who understand what it means to live with GPP https://www.psoriasis.org/gpp-circles/
Ø Join us to create awareness for the first GPP Awareness Day August 13, 2025. Request your tool kit. https://www.psoriasis.org/gpp-toolkit/
Have a red, painful eye that’s sensitive to light? Could be uveitis. Hear ophthalmologist Dr. Timothy Janetos discuss uveitis and how it relates to psoriasis and psoriatic arthritis.
Join host Takieyah Mathis for an eye opening discussion about uveitis, cataracts, and eye health with ophthalmologist Dr. Timonthy Janetos from Northwestern Medicine, Department of Ophthalmology. Listen as they discuss what is uveitis and cataracts from key symptoms, the significance of the HLA-B27 marker, diagnosis, to treatment options that help reduce inflammation and preserve long term vision.
This episode offers information to help you advocate for your eye health by recognizing when you need help from an ophthalmologist and what actions you can take to reduce your risks associated with uveitis.
Timestamps:
· (0:00) Intro to Psound Bytes & guest welcome ophthalmologist Dr. Timothy Milton Janetos.
· (1:21) Definition of uveitis and the relationship to psoriatic disease.
· (5:35) Symptoms of uveitis.
· (7:45) How uveitis is diagnosed.
· (9:24) Treatment options for uveitis.
· (13:11) What happens if eye injections are needed as treatment.
· (14:47) Association between inflammation, psoriatic disease, and cataracts.
· (15:48) Symptoms of a cataract.
· (16:33) Treatment for cataracts.
· (21:11) New advancements in treating uveitis and cataracts.
· (25:50) General eye health actions to help reduce risks associated with inflammation. Early detection is key.
4 Key Takeaways:
· Uveitis is a huge spectrum of different diseases with about half of the associations due to chronic, immune related diseases like psoriasis or psoriatic arthritis.
· If you wake up with a red, painful eye that’s sensitive to light, seek help from an ophthalmologist right away to minimize risk of scar tissue formation.
· Work with a health care team to treat all aspects of psoriatic disease to reduce inflammation whether it’s in the skin, joints, and/or the eye.
· Lifestyle changes such as stop smoking and yearly eye exams are actions that can help reduce inflammatory factors and maintain overall eye health.
Guest Bio:
Dr. Timothy Milton Janetos is a board-certified and nationally recognized ophthalmologist with Northwestern Medicine, Department of Ophthalmology who specializes in uveitis and cataract surgery. He is also an Assistant Professor at the Feinberg School of Medicine, Department of Ophthalmology. Dr. Janetos offers comprehensive care using a personalized treatment plan for both children and adults with intraocular inflammation and infections. He is a professional member of the American Uveitis Society (AUS) and the Association for Research in Vision and Ophthalmology (ARVO), as well as the Editor for Frontiers in Ophthalmology and an Editorial Board Member for Annals of Eye Science.
Resources:
Ø Psoriatic Arthritis and Uveitis: What’s it All About? Podcast with rheumatologist and ophthalmologist Dr. James Rosenbaum. (Released in 2019.) https://www.psoriasis.org/watch-and-listen/psoriatic-arthritis-and-uveitis-whats-it-all-about-psa/
Ø Eye Inflammation and Psoriatic Arthritis
https://www.psoriasis.org/advance/eye-inflammation-and- psoriatic-arthritis/
Osteoporosis is a silent disease. There is no pain or other symptoms but inflammation in the gut and joints is a risk factor. Learn about your risks and what you can do for osteoporosis from rheumatologist Dr. Diana Sandler.
Join host Corinne Rutkowski, a third year medical student, as she explores the relationship between osteoporosis and psoriasis with leading bone health expert and rheumatologist Dr. Diana Sandler. Listen as they discuss the difference between osteoporosis and osteoarthritis, bone density testing, how prolonged inflammation is a key risk factor especially for psoriatic arthritis, along with treatments and actions you can take to minimize your risk of osteoporosis and fractures.
Do what you can to protect your bone health and function as you age.
Timestamps:
- (00:00) Intro to Psound Bytes & guest welcome rheumatologist Dr. Diana Sandler.
- (01:23) Risk factors and difference between osteoporosis and osteopenia.
- (03:10) Difference between osteoporosis and osteoarthritis, which are often confused.
- (04:17) Diagnosis process for osteoporosis.
- (06:11) Risk factors for development of osteoporosis.
- (07:57) Is it possible to have osteoporosis or osteopenia and psoriatic arthritis together?
- (09:44) The role of osteoclast and osteoblasts in bone formation.
- (12:21) Treatment of osteoporosis.
- (14:10) Importance of vitamin D and calcium in the prevention of osteoporosis.
- (15:57) Activities that strengthen the muscles and bones to slow progression of osteoporosis.
- (17:08) Precautions and tips for avoiding falls.
- (18:59) Schedule appointments and ask for referrals early.
4 Key Takeaways:
· Osteoporosis and osteoarthritis are two distinct diseases that affect joints and bone.
· There are many factors that impact the development of osteoporosis including inflammatory diseases such as psoriatic arthritis, lifestyle risks, family history, use of steroids, hormone deprivation, and more.
· Preventive use of bisphosphonates and other treatment strategies can be implemented to address the breakdown of bone in osteoporosis.
· Various precautions can be taken to minimize and avoid falls.
Guest Bio:
Dr. Diana Sandler is a rheumatologist at Endeavor Health in Chicago and is a Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine where she is a leading expert in osteoporosis, psoriatic disease, and other immune-mediated diseases. Dr. Sandler is the Director of the Bone Health Center at Endeavor Health. She is also a board member of the National Psoriasis Foundation and in 2023 received the NPF Provider of the Year award in Rheumatology. Dr. Sandler is passionate about patient education and integrative team approaches when it comes to caring for patients with complex and multilevel diseases such as psoriatic arthritis, psoriasis and osteoporosis.
Not sure what Minimal Disease Activity or MDA is and how it relates to psoriatic arthritis and your joints? Listen as rheumatologist Dr. Arthur Mandelin explains what MDA means.
Join hosts Jeff Brown and LB Herbert as they discuss minimal disease activity in psoriatic arthritis with nationally recognized rheumatologist Dr. Arthur Mandelin who identifies what it is, factors that influence achieving MDA, how long it takes to reach, and the impact on selection of treatments. Dr. Mandelin also addresses fatigue associated with inflammation, and what the future holds for minimal disease activity in psoriatic arthritis.
Whether you have psoriasis or psoriatic arthritis, this episode offers information to help you understand management goals set by your doctor and the importance of attaining minimal disease activity.
Timestamps:
- (00:00) Intro to Psound Bytes & guest welcome rheumatologist Dr. Arthur Mandelin
- (02:23) What is minimal disease activity (MDA)
- (04:32) MDA in comparison to ACR response criteria
- (07:36) Criteria for reaching MDA
- (09:20) Positive and negative factors of MDA
- (11:25) Importance of reaching MDA within a specific time frame
- (17:34) Length of time to reach MDA
- (18:48) Selection of treatment options and psoriatic arthritis domains
- (23:51) Inflammation and fatigue
- (26:59) A look at the future of minimal disease activity in psoriatic arthritis: Reaching ACR 90
- (29:09) Advancements in psoriatic arthritis: Finding disease markers
- (33:40 ) If you have psoriasis, be aware of your risk for psoriatic arthritis
4 Key Takeaways:
- There are various ways to measure minimal disease activity in psoriatic arthritis to assess how the disease impacts quality of life.
- Attaining and keeping minimal disease activity low through use of different therapy options offers a chance for better bone and joint outcomes.
- Advancements in psoriatic arthritis include attaining ACR90 and the potential for identifying key markers that make treatment selection more targeted and individualized.
- Those who have psoriasis need to realize bone and joint pain, and swelling in the joints may be related to their psoriatic skin disease and seek appropriate help.
Guest Bio:
Dr. Arthur Mandelin is an Associate Professor of Medicine at Northwestern University Feinberg School of Medicine and the Department of Medicine Division of Rheumatology. Dr. Mandelin launched Northwestern University’s first training program in musculoskeletal ultrasonography for rheumatology fellows. He is an active participant in the REASON Group which is a multi-center research collaboration devoted to using ultrasound guidance to obtain minimally invasive synovial tissue biopsies. Dr. Mandelin is a past member of the National Psoriasis Foundation’s Medical Board where he served on consensus panels for the development of a variety of practice guidelines.
Resources Mentioned:
- National Psoriasis Foundation: https://www.psoriasis.org
- PEST Screener: https://www.psoriasis.org/psoriatic-arthritis-screening-test/
- PsA Action Month 2025: https://www.psoriasis.org/psa-action-month/
- NSAIDS for Psoriatic Disease: https://www.psoriasis.org/advance/nsaids-for-psoriatic-disease-psa/
- AMP (Accelerated Medicines Partnership): https://www.psoriasis.org/advance/progress-and-success- through-collaboration/
Tags:
psoriasis, skin, psoriatic arthritis, minimal disease activity, ACR20, ACR50, ACR70, tender joints, bone erosion, joint swelling, enthesitis, inflammation, pain, fatigue, axial disease, spinal involvement, treatment, NSAIDS, biologics, personalized medicine, dermatology, National Psoriasis Foundation, AMP, Psound Bytes podcast, Soundbites podcast
Psoriasis in high impact sites like the scalp, nails, genitals, palms, and soles is challenging. Hear views on living with such difficult to treat areas, and how appropriate treatments offer patient centered care from internationally recognized dermatologist Dr. Andrew Blauvelt, chair of the NPF Medical Board, patient advocates Brittany Murray and Crystal Gatlin, with moderator Corinne Rutkowski. This episode is provided with support from AbbVie.
Explore groundbreaking updates in psoriasis and psoriatic arthritis research from the 2025 AAD Annual Meeting with dermatologist Dr. Mona Shahriari.
Join host Archie Franklin and renowned dermatologist Dr. Mona Shahriari as they unpack the latest research and clinical insights into managing psoriatic disease. This episode dives into head-to-head therapeutic trials, fast-acting treatments for high-impact areas like scalp and nails, and a preview of emerging oral biologics and GLP-1 weight management therapies. Dr. Shahriari discusses real-world challenges in treating psoriasis and psoriatic arthritis, the rise of precision medicine, and how early intervention could alter disease progression.
Whether you're a patient, clinician, or researcher, this conversation delivers critical updates on psoriasis care, including IL-17, IL-23, and TYK2 inhibitors, and their potential to revolutionize dermatology practice.
Timestamps: * (00:00) Intro to Psound Bytes & guest welcome Dr. Mona Shahriari * (01:00) What the AAD 2025 conference revealed about psoriatic disease * (02:10) Comparing IL-17 and IL-23 inhibitors: Trial results * (06:00) Treating scalp, palmoplantar, and nail psoriasis * (10:45) Genital psoriasis & the importance of psychosocial care * (12:00) What’s new for Generalized Pustular Psoriasis (GPP) * 14:35) The GUIDE Study: Early treatment & immune memory * (18:00) Personalized medicine, oral IL-23s & emerging TYK2s * (20:00) GLP-1 therapies for weight & inflammation control * (23:00) Psoriasis, cardiovascular risk & comorbidities * (24:00) Mental health, depression & the value of systemic treatment * (26:00) A hopeful future: matching therapy to the patient
4 Key Takeaways: * Head-to-head trials show IL-17s like ixekizumab outperform traditional TNF inhibitors and even some IL-23s in early, fast action. * Precision therapy based on site (scalp, nails, genitalia) and comorbidities is now guiding real-world treatment selection. * GLP-1 medications are emerging as effective adjuncts for psoriasis patients struggling with weight and inflammation. * Early intervention—especially with IL-23 inhibitors—may reduce flares, limit disease progression, and improve mental health outcomes.
Guest Bio: Dr. Mona Shahriari is an Associate Clinical Professor of Dermatology at Yale University and Co-Founder of Central Connecticut Dermatology. A leading voice in inflammatory skin conditions, she serves as Associate Director of Clinical Trials and Senior Editor for the Journal of Psoriasis and Psoriatic Arthritis, a National Psoriasis Foundation peer reviewed journal for health care providers. Dr. Shahriari is also a National Psoriasis Foundation Medical Board Member and frequent contributor to dermatological research and clinical education.
Resources Mentioned: * National Psoriasis Foundation: https://www.psoriasis.org * Subscribe to the Advance eNewsletter: https://www.psoriasis.org/subscribe * AAD Annual Meeting Info: https://www.aad.org * Learn More About Clinical Trials: https://clinicaltrials.gov
Tags: psoriasis, psoriatic arthritis, IL-17, IL-23, biologics, personalized medicine, dermatology, GLP-1, weight management, immune memory, AAD 2025, TYK2 inhibitors, Dr. Mona Shahriari, National Psoriasis Foundation, Psound Bytes podcast, Soundbites podcast
Facing challenges presented by psoriasis can be an emotional roller coaster. From diagnosis, treatment choices, and the impact of bullying when a child has psoriasis can leave a parent feeling alone and helpless. Finding someone who's been on the same journey can be a benefit. Hear how parents Jessie Houston, Nadya Helt, and Emma Rhodes with moderator Michel Tarabocchia found the help and hope they needed through the NPF One to One Program.
Making an impact as a volunteer can happen in many different ways. Hear what it means to volunteer and come together to attend the NPF IMPACT Volunteer Leadership Summit as 3 fabulous volunteers, John Romano, Alena Chapman, and NPF Board Member Chris Lindsay, share their experiences and how they fundraise to make a difference in the psoriatic disease community with Carol Osterhaus, NPF Senior Regional Development Manager for the Central Region.
Having psoriasis may mean you're at risk for other diseases. Listen as moderators Alan Simmons and Kaleigh Welch explore cardiovascular disease, calcium build-up, NAFLD, sleep disorders, depression, anxiety, and the big question - does risk equal certainty with Dr. John Barbieri, Assistant Professor at Harvard Medical School, an investigator of the CP3 Study, and the Smart Phone Cognitive Behavioral Therapy Study.
The journey from the first sign of plaque psoriasis to diagnosis and beyond is very familiar to Brandon, Christy and Daryl. Hear these real patients share the good and the bad of their plaque psoriasis journeys with moderator Max Blitstein. Listen as they discuss how they became empowered self advocates by speaking up for themselves with their healthcare provider. What differences did it make for them? Tune in to find out. This episode is sponsored by Arcutis Biotherapeutics, Inc. Please see Important Safety Information and full Prescribing Information for the product mentioned in this podcast.
Inverse psoriasis is more challenging to treat and to keep under control. Learn more as we uncover inverse psoriasis from what it is, typical symptoms and sites, other potential diseases, to being a risk factor for psoriatic arthritis, and what treatments are used either alone or in combination with dermatologist Dr. Jeffrey Cohen, Director, Psoriasis Treatment Program at Yale University School of Medicine and moderator Kaitlin Walden, RN.
Listen as Jeff Brown, LB Herbert, and Kaitlin Walden share their insights on partnering with doctors, advocating for your health, and navigating relationships - whether it's dating, family, or work. They also explore the challenges of living with a visible skin disease like psoriasis and the hidden struggles of psoriatic arthritis. As LB Herbert wisely puts it "We've all got baggage. It just might be a different type of luggage".
Listen to this unique episode that is so good it had to be split into two episodes! Hear our moderators Jeff Brown, LB Herbert, and Kaitlin Walden comment honestly on what it means to live with psoriasis and psoriatic arthritis from the challenge of not knowing what each day brings, feeling confident, coping with fears, medication changes, to advocating for your own health care. It's possible you may feel the same way and learn a few tips too.
Hear this inspiring conversation about living with psoriasis as a child, being diagnosed with PsA later, and treating with a biologic from teen Sophia and college student Jackie with moderator Kaleigh Welch. Listen to their treatment journey, overcoming fears of using a biologic, and what tips they use to live each day not defined by their psoriatic disease. This episode is provided with support from Bristol Myers Squibb.
Join moderator Emily Wallack as we hear how Mark, a patient living with moderate-to-severe plaque psoriasis, rediscovered self-love after finding ILUMYA® (tildrakizumab-asmn), a treatment that he receives for little to no cost with coverage under Medicare Part B with a supplement. Dermatologist Dr. Omar Noor also joins to offer insights on diagnosing and treating psoriasis. This episode is sponsored by Sun Pharma. To view important safety information: ilumya.com
Clinical studies are not always representative of the actual patient population, which can limit our understanding of patient outcomes. Join NPF moderator Takieyah Mathis as we hear from LaShell Robinson and Marygrace Corral with Takeda on why it's so important to ensure diversity in clinical research, what they are doing to improve racial diversity in their clinical studies, and how you can support these efforts. This episode is sponsored by Takeda.
On this episode, we'll talk about redefining remission - when a patient and their healthcare practitioner work together to discuss and create a personalized approach to psoriatic arthritis care with moderator Jeff Brown and guests Noelia Ferreyra, a patient advocate living with psoriatic disease, and Dr. Saakshi Khattri, a dermatologist/rheumatologist in New York who serves on the medical board of the NPF. This podcast is sponsored by UCB.
Plaque psoriasis is a lifelong disease with no cure, but living well with clearer skin is possible. This World Psoriasis Day dermatologist/rheumatologist Dr. Alice Gottlieb discusses the benefits of a once-daily, steroid-free prescription treatment for adults with plaque psoriasis. Discover how this effective, safe and well-tolerated option can help manage plaque psoriasis, even on affected sensitive areas. This episode is sponsored by Dermavant Sciences.
In 2025 key changes impact Medicare beneficiaries. Listen as Jason Harris, NPF VP of Government Relations & Advocacy and dermatologist/rheumatologist Dr. Alice Gottlieb with the Dept. of Dermatology, Icahn School of Medicine at Mount Sinai, discuss issues and tips for transitioning to Medicare health coverage, the $2,000 expense cap, and smoothing expenses. This episode is made possible with support from Sun Pharma and Novartis.
Over 20 years ago biologics were introduced for psoriasis and PsA. Since then even more targeted treatments have been introduced. Listen as dermatologist Dr. Steven Feldman from Wake Forest University School of Medicine, shares his perspectives on the latest treatments, resident memory T-cells, and what's to come (such as an oral IL-23 agent) with moderator Max Blitstein. This episode is provided with support from Bristol Myers Squibb.
Patient advocate Alisha Bridges and dermatologist Dr. Mona Shahriari discuss a study dedicated to people of all skin tones who have moderate to severe plaque psoriasis. Dr. Shahriari also shares her experience guiding people with skin of color as they navigate their psoriasis journey. This episode is sponsored by Johnson & Johnson. Please see Important Safety Information and full Prescribing Information for the product mentioned in the podcast.
Psoriasis is not just a skin disease. It's about inflammation. Listen as dermatologist Dr. Chesahna Kindred at Kindred Hair and Skin Center, and moderator Michelle Zimmerman discuss related diseases that people with psoriasis are at risk of developing like uveitis, heart disease, IBD, PsA and more. Hear what screenings and actions you can take to control what you can. For our episode sponsors please check our web page at psoriasis.org/watch-and-listen/.
Moderator Renee Joyce asks dermatologist Dr. James Song at Frontier Dermatology Partners for his response to questions from you, our listeners like: What triggers psoriasis and how to avoid it? Can diet help scalp psoriasis? How to treat psoriasis on the face, neck or in the mouth? What type of psoriasis makes you prone to PsA? What's Woronoff's ring? When should treatment be started? This episode is provided with support from Bristol Myers Squibb.
Living with pustular psoriasis is tough. Hear the latest updates about heritable aspects of GPP, diagnosis, management tips, and treatment options such as the IL-36 inhibitor spesolimab, how it works and how effective it is from dermatologist Dr. Laura Ferris, Professor of Dermatology at the University of Pittsburgh and moderator Alan Simmons. This episode is provided with support from our Psoriasis Action Month sponsors.
Join NPF moderator LB Herbert as NPF patient volunteers Sam Blonien and Jeff Brown get candid about their experience living with psoriasis (PsO) and psoriatic arthritis (PsA). Hear from Sam and Jeff, along with commentary from Dr. Andrea Murina, on the potential connection between PsO and PsA, the importance of finding the right doctor, and where to find helpful resources. This episode is sponsored by Novartis Pharmaceuticals Corporation.
Is it possible your flare of psoriasis is due to products or medications you use? Learn what medications for high blood pressure, depression, anxiety, pain (NSAIDS), or infection can potentially flare psoriasis, and what paradoxical psoriasis is from Clinical Dermatology Pharmacist Lacey Glover, Pharm.D., University of Alabama Medicine, and moderator Kaitlin Walden, RN. This episode is provided with support from Bristol Myers Squibb.
Hear results from the Light Treatment Effectiveness (LITE) Study comparing home vs office based phototherapy for psoriasis with renowned dermatologist Dr. Kristina Duffin, Chair, Dept. of Dermatology, University of Utah, as she discusses benefits, innovations, and barriers with Dr. Guy Eakin, NPF Chief Scientific & Medical Officer. The LITE Study is funded with support from PCORI (Patient Centered Outcomes Research Institute) and the Daavlin Company.
Over the past year NPF has gathered insights from the psoriatic disease community to develop a new 5 year strategic plan. Join Matt Werbach, NPF Associate Director of Media and Communications as he speaks with NPF President and CEO Leah Howard, and Board Member Rick Seiden about the plan, milestones towards a cure, and steps to help improve the health of those with psoriatic disease. This episode is provided with support from Bristol Myers Squibb.
Being a couple has its challenges. When do you let someone know you have psoriasis? What do you do to be a great partner? Hear Licensed Professional Counselor Mary Maraventano Stried chat with Lori and Howard Chang, who has had psoriasis for 45 years, about key ingredients to navigating life together for 30 years from acceptance, open communication, frustrations, and burnout. This episode is provided with support from Bristol Myers Squibb.
Curious about Take Action for Psoriatic Disease? Listen as volunteers Kendra, Frank and Elizabeth tell their story to Kristin Brooks, Associate Director of Field Development about why they participate and support NPF's efforts to educate, advocate, and connect with the psoriatic disease community. Hear tips on how they raise funds and create awareness to enhance the lives of those with psoriatic disease. It's a long-lasting love affair.
Is your aching back due to axial involvement with PsA? Learn about the sacroiliac joint to the cervical spine from rheumatologist Dr. Atul Deodhar, Medical Director, Rheumatology Clinics at OHSU with Alan Simmons as moderator. Hear about key symptoms, treatment options which may differ from peripheral joints, research, and management challenges. This episode is provided with support from Bristol Myers Squibb, Amgen, Johnson & Johnson, and UCB.
Psoriatic arthritis can affect many areas or domains which includes enthesitis, dactylitis, and more. Learn about the PsA domains and how they influence choice of treatments from rheumatologist Dr. Arthur Kavanaugh, Director of the Center for Innovative Therapy in the Division of Rheumatology, Allergy and Immunology at UCSD. This episode is provided with support from Bristol Myers Squibb, AbbVie, Amgen, Johnson & Johnson, Novartis and UCB.
Just having psoriasis is a huge life transition let alone adapting to life after high school. Listen as moderator Kaleigh Welch asks Youth Ambassadors Emme, Zoe, and Mandy to share their psoriasis journey of being responsible for their own health care, balancing college life with school, relationships, and their physical and mental health to achieve their post high school dreams. This episode is provided with support from Bristol Meyers Squibb.
"I've had psoriasis for most of my life. At 40 years old I experienced the worst flare with all types of psoriasis and the loss of my hair." Join NPF volunteers, Ayesha Patrick, founder of Sistas with Psoriasis, and moderator LB Herbert as they discuss Ayesha's story from how she learned to cope, to ask and give help. Hear her tips to help manage psoriasis and psoriatic arthritis. This episode is provided with support from Bristol Myers Squibb.
"Patients with psoriasis have a lot of undiagnosed and untreated cardiovascular risk factors" per renowned dermatologist Dr. Joel Gelfand, Director, Psoriasis & Phototherapy Treatment Center at Penn. Hear why with moderator Dr. Guy Eakin, NPF Chief Scientific & Medical Officer, as they discuss risks, and what interventions using a centralized care coordination model (CP3) can do. This episode is provided with support from Bristol Myers Squibb.
Not sure what Irritable Bowel Disease or Irritable Bowel Syndrome mean or how they relate to psoriasis? Listen as gastroenterologist Dr. Lisa Malter, Professor in the Dept. of Medicine, NYU Langone Health, Grossman School of Medicine, discusses the perfect storm of what it takes to develop IBD, how diagnosis occurs, care, and use of treatments also used with psoriatic disease. This episode is provided with support from Bristol Myers Squibb.
Interested in participating in a clinical trial? Hear the facts about how and why you should be involved, potential benefits and challenges, what occurs in phase 1, 2, 3 and 4, clinical trial updates for psoriasis and an intriguing one for high blood pressure from dermatologist Dr. Benjamin Ehst, owner and Lead Clinical Investigator at Oregon Medical Research Center in Portland, OR. This episode is provided with support from Bristol Myers Squibb.
Hear answers to questions when someone is newly diagnosed with psoriasis like what to expect at the first appointment, types of psoriasis, triggers of disease, treatments including over-the-counter options, how to deal with negative comments, and more from Tirsa Quartullo, a doctoral prepared, board-certified Dermatology and Family Nurse practitioner at Arizona Dermatology & Cosmetic Surgery in Phoenix. Her advice: "learn as much as you can."
Jillian who is living with plaque psoriasis, and board-certified nurse practitioner, Melodie Young, discuss disease management with topicals. This episode is sponsored by Arcutis Biotherapeutics, Inc. Please see Important Safety Information and full Prescribing Information including Patient Information for Zoryve (roflumilast) indicated for use on the skin (topical), including in areas with skin folds, to treat plaque psoriasis in people six years of age and older.
Knowing what to ask and when will help you make key decisions about psoriasis and psoriatic arthritis. Listen as key terminology, questions to ask about the disease, and use of medications like "what prescriptions and over the counter medications may conflict with psoriatic disease" are discussed with NPF volunteer Dr. Kim Benner, a pharmacist at Children's of Alabama Hospital and Pharmacy Professor at Samford University in Birmingham, Alabama.
On this episode we'll talk about shared decision-making - when a patient and their healthcare practitioner work together to discuss and create a personalized approach to care with guests Karen Camp, a patient advocate who is living with psoriasis, and Dr. Jason Hawkes, a medical dermatologist in the greater Sacramento area who serves on the Medical Board and Scientific Advisory Committee of NPF. This podcast episode is sponsored by UCB.
Hear the latest treatments, challenges, research towards understanding psoriatic disease, and how treatment planning and collaboration is key from dermatologist Dr. Lara Wine Lee, Director Pediatric Dermatology at Medical University of SC, and rheumatologist Dr. Pam Weiss, Clinical Research Director, Division of Rheumatology, Children's Hospital of Philadelphia. This Psound Bytes episode is provided with support from Janssen and Novartis.
Listen to this compelling discussion about when psoriasis should be considered severe and what that means for treatment choices in high impact areas like the scalp, nails, palms, soles, face, and genitalia with dermatologist Dr. Andrew Blauvelt, Investigator at Oregon Medical Research Center, Chair of the NPF Medical Board, and member, International Psoriasis Council. This Psound Bytes episode is sponsored by Amgen.
The holidays bring mixed emotions and stress. Join psychiatrist Dr. Vanessa Cutler, NYU Langone Health and Dr. Leslie Beth or LB Herbert for tips on managing holiday stress and simplifying expectations while also looking out for your physical and mental health to help avoid flares of your psoriatic disease. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, Novartis, and UCB.
Generalized Pustular Psoriasis (GPP) is a rare, inflammatory skin disease that is different from plaque psoriasis. Join UC Davis and UCSF Asociate Professors of Dermatology, Dr. Jason Hawkes and Dr. Tina Bhutani, with Dale Reisner, a patient living with GPP, for a closer look at GPP, some of the difficulties living with the disease and the difficulties dermatologists face managing it. This Psound Bytes episode is provided with support from Boehringer Ingelheim.
With increasing release of biosimilars, listen to this discussion about use, fear of change, dual pricing strategies and who will see cost savings with Jason Harris, NPF VP of Government Relations and Advocacy, dermatologist and past chair of the NPF Board Dr. Colby Evans, and Anna Hyde, VP of the Advocacy and Access Department at the Arthritis Foundation. This Psound Bytes episode is sponsored by Sandoz and Boehringer Ingelheim.
Hear how dermatologist Dr. Ahmad Shatil Amin, Director of the Psoriasis Program and rheumatologist Dr. Eric Ruderman, Associate Chief, Division of Rheumatology, Co-Directors of the Multidisciplinary Psoriasis and Psoriatic Arthritis Clinic, Northwestern Medicine, Chicago, use the ultimate team approach to manage triggers and flares of psoriatic disease. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, Novartis, and UCB.
In this episode, dermatologists Dr. April Armstrong and Dr. James Song discuss the impact of psoriasis on a patient's quality of life and how steroid-free prescription topical medications can meet the treatment needs of adults with plaque psoriasis. This Psound Bytes episode is sponsored by Dermavant Sciences.
Are you losing your hair? Is it connected to your psoriasis? Hear certified dermatology nurse practitioner Victoria Garcia-Albea with Lahey Dermatology Hair Loss Center for Excellence in Burlington, MA as she addresses common causes of hair loss, symptoms, connection to IL-33, current and upcoming treatment options. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, Novartis and UCB.
Ever experience the frustrating itch scratch cycle? Join us as dermatologist Dr. Shawn Kwatra, Director of the Johns Hopkins Itch Center in Baltimore, MD discusses why itch occurs in psoriasis, what factors impact itch, treatment options, and the frontier exploring new therapies that impact the neuroimmune axis. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.
Despite the availability of many treatment options for moderate-to-severe plaque psoriasis, there is still a need for additional therapies. Hear from Ryan Moslin, Principal Scientist, BMS, who has moderate-to-severe plaque psoriasis and Tom Scharnitz, M.D., the Senior Director and US Medical Lead for Dermatology, as they provide the science and research behind an oral treatment for moderate-to-severe plaque psoriasis.
Hear the inspiring responses to questions from you-our listeners! Hear responses to questions about treating scalp psoriasis, over-the-counter options, when treatments lose effectiveness, biosimilars, and more from board-certified Family Nurse Practitioner Sandri Johnson at Midtown Dermatology in Raleigh. This special Psound Bytes episode is provided with support from Bristol-Myers Squibb, CeraVe, Janssen, Novartis, and UB.
Plaque psoriasis is the most common type of psoriasis. If you have plaque psoriasis, join us as we discuss what to know from symptoms, diagnosis, triggers and flares, to treatment options with dermatologist Dr. David Rosmarin, Chair of the Department of Dermatology at Indiana University School of Medicine in Indianapolis. This Psoriasis Action Month episode is provided with support from CeraVe and Novartis.
Topical steroids are the first treatment of choice for mild psoriasis. Learn what the options are from dermatologist Dr. George Han, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health in New York as he discusses low to superpotent strengths, risks, side effects, tips for using, and new nonsteroidal topicals. This Psound Bytes episode is provided with support from Bristol Myers Squibb, CeraVe, Janssen, Novartis, and UCB.
Hear Todd's journey to finding skin clearance with the help of ILUMYA® (tildrakizumab-asmn) for his moderate-to-severe plaque psoriasis. Victor Czerkasij, a nurse practitioner with over 20 years of experience treating patients with psoriatic disease, joins to offer insights on diagnosing, treating, and managing psoriasis. This episode is sponsored by Sun Pharma. Important safety information: https://bit.ly/2We7fIS .
Listen as Matt Werbach, Associate Director of Media and Communications, discusses NPF's promising research activities and efforts to change health outcomes for all with psoriasis and psoriatic arthritis with President and CEO Leah Howard, and Chief Scientific and Medical Officer Guy Eakin. Exciting times ahead as NPF moves towards a new chapter! This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.
Join board-certified Family Nurse Practitioner Jayme Heim from West Michigan Dermatology Associates, Grandeville, MI, as she offers tips, her favorite products, and what medications help manage psoriasis plaques and itch on the scalp, skin, nails and everything in-between since psoriasis is about managing what's on the outside and inside. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.
Trying to follow an anti-inflammatory diet? Not sure what to eat? Join us as we discuss what types or combinations of foods are best to eat and when, what to look for on food labels, how much sugar and fiber intake is appropriate, and more with registered dietitian and wellness coach, Brittany Link from Advice for Eating in Houston, TX. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.
Hear Dr. Shawn Kwatra, M.D., Associate Professor, Department of Dermatology at Wake Forest School of Medicine and Director of John Hopkins Itch Center, discuss pathogenesis of itch, histaminergic pathways, treatments and more.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from AbbVie and Novartis.
Hear the latest about step therapy from what it is to current legislative reform progress. Listen as Jason Harris, Vice President of Government Relations and Advocacy, discusses all aspects of step therapy with Sarah Buchanan, Director of Federal Government Relations and Health Policy, and Sam Cox, State Government Relations Manager. This Psound Bytes episode is provided with support from Bristol Myers Squibb.
Can nutrition choices impact psoriasis and PsA? Hear the facts from dermatologist Dr. Ronald Prussick, Medical Director of the Washington Dermatology Center in Rockville, MD, as we explore anti-inflammatory diets, the glycemic index, sugar alcohols, caffeine intake, and other research around nutrition and the impact on severity of psoriatic disease. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen and UCB.
There are many ways to be physically active if you experience chronic pain. Hear Dr. Connor Hurley, Co-Director of Physical Therapy, Therapeutic Associates Bethany in Portland, OR, offer tips for starting an exercise program, types of low impact activities, cautions, and how to integrate activity into everyday life. This Psoriatic Arthritis Action Month episode is provided with support from AbbVie, Bristol Myers Squibb, Janssen, and UCB.
Hear the answer to this question and more about the synovio-entheseal complex in PsA, and how it can be a biomarker for more severe disease from rheumatologist Dr. Lihi Eder, Associate Professor of Medicine and the Canada Research Chair, Inflammatory Rheumatic Diseases Tier 2 at the Institute of Medical Science, University of Toronto. This Psound Bytes episode is provided with support from AbbVie, Bristol Myers Squibb, Janssen, and UCB.
Are topicals not enough to treat your psoriasis? Are you considering systemic treatments? Listen as Dr. Ahmad Shatil Amin, Medical Practice Director, Northwestern Medicine Dermatology Department in Chicago, discusses what oral and injectable systemic treatments are available, how they work, potential side effects, use in combination therapy, and more! This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen and UCB.
Join us as we discuss life with psoriatic disease and how those experiences shaped the lives of two amazing NPF volunteers, Melissa Leeolou and Max Green, who now pursue a career in medicine. Hear how they came to volunteer with the National Psoriasis Foundation and why they dedicate their lives to helping others through life's challenges. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.
Life is not always rainbows and butterflies. Sometimes it's tough and having psoriasis or PsA can make it harder. You are not alone. Hear words of wisdom from One to One Program mentors Alan Simmons and Renee Joyce as they share experiences and tips on how to move past fears and every day stressors to enjoy life. Don't miss this amazing episode! This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen and UCB.
Hear what this means from long-standing NPF volunteer Dr. Meyer Horn, Medical Director, Dermatology and Aesthetics in Chicago and Julia Hamel, NPF Midwest Regional Development Manager as they share ideas from volunteers about new ways communities can take action, connect with each other, and support NPF's mission critical programs. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.
If you have psoriasis you could be at risk for infections. Hear Katie Chambers share her experience with infections with dermatologist Dr. Seth Forman at ForCare Dermatology, Tampa, FL, who presents types of bacterial infections and viruses that trigger or make psoriasis worse, signs of sepsis, complications and treatments that impact risk of infection. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen and UCB.
Just how effective is phototherapy and where can it be used? Join us to hear renowned dermatologist Dr. Joel Gelfand, Director of the Psoriasis and Phototherapy Treatment Center at University of Pennsylvania as he answers such questions about phototherapy and more like frequency, duration, side effects, risks, and cardiovascular benefits. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.
Psoriasis is usually more extensive and severe in skin of color. Hear dermatologist Dr. Mona Shahriari from Central Connecticut Dermatology address why and how psoriasis presents in skin of color, potential for misdiagnosis, hyper/hypopigmentation, cultural beliefs, and cautions to consider when treating psoriasis in skin of color. This program is supported by educational grants from Amgen, Bristol Myers Squibb, CeraVe, Janssen, and UCB.
Do you want to make your dermatology health care appointments more effective? Not sure if you're preparing enough for your appointments? Hear Kirk Gautier, a certified physician assistant with US Dermatology Partners in Tyler and Athens, TX offer tips from what to bring and do to help prepare and make the most of your health care appointments. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen and UCB,
Transitions in life impact us all. When it impacts your psoriatic disease care you need options. Listen as we discuss transitions that might mean a change in your treatment such as pregnancy, surgery, insufficient efficacy, and more with NPF Medical Board member Dr. Clive Liu, Director of the Psoriasis Treatment Center at Bellevue Dermatology. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.
Adhering to treatment can be challenging. So many factors impact adherence and ultimately treatment outcomes. Listen as we explore the issues of why treatment adherence matters and what you can do about it with the leading expert on this topic, dermatologist and skin pathologist Dr. Steven Feldman from Wake Forest School of Medicine in Winston-Salem, NC.
You may have heard about erythrodermic psoriasis but just what is it? Dr. Mio Nakamura from the University of Michigan, Dept. of Dermatology answers questions about this serious and potentially life-threatening form of psoriasis from types, symptoms, need for acute care, to potential triggers, treatment options and risk of skin infections. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.
Hear Dr. Vanessa Cutler, MD, Clinical Assistant Professor, Department of Psychiatry at NYU Grossman School of Medicine, discuss the impacts body dysmorphic disorder has on patients living with psoriatic disease.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Have questions about JAK inhibitors? Not sure how they work, what they treat, risks and how effective they are compared to other treatments? Listen as rheumatologist and NPF Medical Board member, Dr. Sergio Schwartzman from Weill Cornell Medical Center in NY, addresses such questions and more about the JAK STAT pathway. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.
Topical therapies are a mainstay of psoriasis care but can be challenging to use. Hear what challenges they present and how the latest topicals - Tapinarof and Roflumilast could revolutionize topical treatments from dermatologist and NPF Medical Board member, Dr. Larry Green, Aesthetics and Dermatology Center in Rockville, MD. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.
Join dermatologist Dr. Jason Hawkes, Associate Professor of Dermatology at the University of California, Davis, as he breaks down the immune pathways and feed forward mechanism driving the development of psoriasis and psoriatic arthritis, and why the IL-17/IL-23 axis is key to the development of targeted treatments for this disease. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.
Treatment options backed by real-world evidence means more opportunities for those living with moderate-to-severe plaque psoriasis. Join Steve Rozzo, Ph.D., Sun Pharma, and Neal Bhatia, M.D., Therapeutics Clinical Research in San Diego, CA in a Q&A discussion on real-world clinical data of ILUMYA® and what the findings mean for moderate-to-severe plaque psoriasis patients. Episode sponsored by Sun Pharma. Important safety information: https://bit.ly/2We7fIS .
Hear renowned rheumatologist Dr. Elaine Husni from the Arthritis and Musculoskeletal Treatment Center at Cleveland Clinic discuss with patients Brian LaFoy and Brandon Robert myths and solutions for changing lifestyle habits that can impact PsA and SpA care. This is the last episode in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN and SAA. This program is supported by an educational grant from Pfizer Inc.
Psoriasis is a lifelong disease with no cure, but that doesn't mean you can't thrive in your everyday life. Listen as board-certified dermatologist Dr. Mona Shahriari, shares tips to overcome plaque psoriasis and maintain a high quality of life. This Psound Bytes™ episode is sponsored by Dermavant Sciences. For Important Safety and Prescribing Information visit VTAMA.com.
Listen as renowned rheumatologist Dr. Atul Deodhar from OHSU in Portland, OR, meets with patients John Latella and Roz Tolliver to discuss the latest treatments for PsA and spondyloarthritis or SpA, management tips, and how treatment choices are identified. This is the third episode in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN and SAA. This program is supported by an educational grant from Pfizer Inc.
Chronic pain and fatigue in PsA and spondyloarthritis can be challenging. Rheumatologists Dr. Philip Mease (Seattle Rheumatology Associates) and Dr. Ernest Choy (Cardiff University School of Medicine), with patients Melissa and Mini discuss causes, symptoms, risks and tips for managing both successfully. This is the second episode in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN and SAA.
Did you know PsA and fibromyalgia can coexist? Knowing whether it's fibromyalgia, PsA or both can impact your treatment options. Listen as rheumatologist Dr. Evan Siegel from Arthritis and Rheumatism Associates in Rockville, MD, discusses symptoms, similarities, differences and treatment options. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb, Janssen, Lilly and Pfizer.
Lakshi Aldredge, board-certified Dermatology Nurse Practitioner with the VA Portland Health Care System, answers questions from around the world about skin and scalp psoriasis such as the best soap and moisturizers, over-the-counter sunscreen, hair care products to avoid, what to look for in shampoos and conditioners, and more. This Psound Bytes episode is provided with support from CeraVe, AbbVie, Amgen, Bristol Myers Squibb, Janssen and Lilly.
Curious about the Mediterranean Diet and impact on psoriatic disease? Dr. Adam Ford, UC Davis Health, Dept. of Dermatology and registered dietitian, Danielle Baham, Supportive Oncology & Survivorship, UC Davis Comprehensive Cancer Ctr, discuss evidence supporting use, and how changes lead to improved therapy response and reduce risk of related health conditions. This Psound Bytes episode is provided with support from AbbVie, Amgen, CeraVe, Bristol Myers Squibb, Janssen and Lilly.
Hear cardiologist Dr. Nehal Mehta, Chief, Section of Inflammation and Cardiometabolic Diseases at the NIH in Bethesda, MD provide an update on the role "adipokines" play in the development of inflammatory diseases such as psoriasis, along with tips on reducing your inflammatory risk. This Psound Bytes episode is provided with support from AbbVie, Amgen, CeraVe, Bristol Myers Squibb, Janssen and Lilly.
Join rheumatologist Dr. Hema Srinivasalu from Children's National Hospital in WA D.C., Wendy Olsder, Asad Khan and Aamena Hameed as they answer what is Juvenile Spondyloarthritis, how it relates to psoriatic arthritis, typical symptoms, diagnosis, treatments and what it means to live with JSpA. This is the first in four CAPES (Clinician and Patient Education Series) episodes presented by NPF, GRAPPA, SPARTAN and SAA.
Listen as dermatologist Dr. Laura Ferris, Professor of Dermatology at the University of Pittsburgh, joins us to talk about the primary types of skin cancer, how it compares to psoriasis, risk factors (including those associated with medications), diagnosis, treatments, and tips to protect your skin while in the sun. Psound Bytes is supported by unrestricted educational grants from AbbVie, Amgen, Bristol Myers Squibb and Janssen.
We've heard biosimilars have been coming for a while. Now hear the latest news from Julie Reed, Executive Director with the Biosimilars Forum who answers questions about what biosimilars can be used for psoriasis, the meaning of terms such as reference product and interchangeable, and how biosimilars are proven to be safe, effective and lower cost.
Given the expansion of CBD products, dermatologist Dr. Jason Hawkes, Associate Professor of Dermatology at the University of California, Davis, returns to provide an update on the current landscape of CBD products for symptoms of psoriasis and psoriatic arthritis. Includes survey results from the Medical Board assessing provider attitudes and knowledge of medical cannabis use.
Celebrity chef and restauranteur, Michelle Bernstein, joins us to speak for the first time about her experience with psoriatic arthritis (PsA) - from information she wished she knew to tips on how to advocate for yourself with your doctor. This episode is sponsored by Novartis Pharmaceuticals Corporation.
Hear Theo Ahadome, SVP of Commercialization at Happify Health, discuss how Kopa provides free digital care tools for people with psoriasis and psoriatic arthritis. Members receive community support, personalized content, advice from experts, and symptom trackers to help meet their mental and physical health needs. Learn more and take control of your health at kopa.com.
Learn more about body dysmorphia, symptoms and its relationship to psoriatic disease and self-esteem from psychiatrist Dr. Vanessa Cutler with NYU Langone Health and Dept. of Psychiatry at NYU Grossman School of Medicine. Family members listen to this episode to catch behaviors that might indicate when help is needed. Psound Bytes is supported by unrestricted educational grants from AbbVie, Amgen, Bristol Myers Squibb, Janssen, and Lilly.
Disparities exist across various types of clinical trials, and there is a need to bridge the gap between community and science. Listen as Krista Wixted, Program Delivery Lead at UCB, and Juma Mohamad Harun, who lives with psoriasis, promote and discuss inclusion of diversity in clinical trials, what UCB is doing to meet such needs, and how it is working to include "someone like me" in its clinical trials and community engagement programs.
Discover how the legacy of paying it forward began for four extraordinary One to One Program mentors - John Latella, Jaime Moy, Michel Tarabocchia and Jessica Houston. Hear their incredible stories about life with psoriasis and psoriatic arthritis from treatment choices to how they found help when they needed it most. Psound Bytes is supported by unrestricted educational grants from AbbVie, Amgen, Bristol Myers Squibb, Janssen, and Lilly.
Hear the amazing stories of NPF Youth Ambassadors Emme and Neel who share their "origin" of when they were first diagnosed, how they tell others about their disease, to how they cope with the positives and negatives of living with psoriasis and psoriatic arthritis. Both will inspire you to celebrate being unique! Psound Bytes is supported by unrestricted educational grants from AbbVie, Amgen, Bristol Myers Squibb, Janssen, and Lilly.
Ever face the frustration of insurance denials for psoriatic disease treatments you need? Hear Elle Hurley, a member of the Patient Navigation Center Team and Sam Cox, State Government Relations Manager, offer tips to address insurance denials from steps you can take, what to document, and who to contact if an external appeal is needed. This episode is supported by unrestricted educational grants from Bristol Myers Squibb, Janssen and Lilly.
World renowned pediatric dermatologist Dr. Amy Paller from Northwestern University, Feinberg School of Medicine, returns to share the latest news about current and upcoming treatments along with an update on her research efforts to improve the management of youth with psoriasis and psoriatic arthritis. If you're a parent don't miss this episode! This episode is supported by unrestricted educational grants from Janssen, Lilly and Novartis.
Ever wonder how treatments for psoriasis and psoriatic arthritis work? Listen as experts, dermatologist Dr. Brad Glick, Glick Skin Institute in Margate, FL, and rheumatologist Dr. Arthur Kavanaugh, Division of Rheumatology at UCSD, San Diego, discuss treatments from topicals to biologics and what factors impact their treatment decisions. This episode is supported by unrestricted educational grants from Bristol Myers Squibb, Janssen, and Lilly.
For years, Maureen struggled with symptoms of plaque psoriasis while on the job as an attorney. Hear Maureen's story on learning to advocate for herself and pushing for change in her treatment routine. This episode is sponsored by Amgen. For Important Safety Information https://bit.ly/2CzZ6Ym and for Prescribing Information https://bit.ly/3hclnuA .
While acne and psoriasis are two of the most common skin conditions, having both can be challenging. Hear dermatologist and NPF Medical Board member, Dr. Lawrence Green, Aesthetics and Dermatology Center in Rockville, MD, offer tips to help differentiate the two from locations, triggers, hyperpigmentation, and treatments. Psound Bytes is supported by unrestricted educational grants from Amgen, AbbVie, Bristol Myers Squibb, Janssen and Lilly.
Thinking of starting a family? Listen as dermatologist Dr. Jenny Murase from UCSF addresses considerations for family planning, pregnancy and psoriasis which includes fertility, genetic risk, flares, treatment choices, and why it's important to have a discussion with a dermatologist prior to becoming pregnant. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Treating scalp psoriasis can be problematic. Tirsa Quartullo, a doctoral prepared, board-certified family nurse practitioner with Arizona Dermatology and Cosmetic Surgery in Phoenix, AZ, shares practical tips, over-the-counter products and cautions for care of scalp psoriasis. This Psound Bytes episode is supported by unrestricted educational grants from Amgen, Janssen and UCB.
Maintaining healthy skin and managing moderate-to-severe plaque psoriasis go hand in hand. For those with psoriasis, it's more than just symptoms. Listen as Barry and Tommy discuss their journeys with moderate-to-severe plaque psoriasis and life with lasting skin clearance. Dr. Daniel Carrasco joins them to discuss a treatment option for moderate-to-severe plaque psoriasis. This podcast episode is sponsored by Sun Pharma. For important safety information: https://bit.ly/2We7fIS .
Could dietary supplements offer a new lighter option for alleviating psoriasis symptoms? Hear from SkinBioTherapeutics CEO Stuart Ashman and CSO Dr. Catherine O'Neill about the science behind leveraging the gut-skin axis to improve skin health through a targeted blend of bacteria and from Chris, one of the participants in their recent study about his experience with his psoriasis. This episode is sponsored by AxisBiotix.
Celebrate World Psoriasis Day with NPF Medical Board member rheumatologist Dr. Soumya Reddy, NYU Langone Health, and Lisa Albany, AAD's Director of State Advocacy to hear how NPF, AAD, GRAPPA and PPACMAN work to build unity around policy, education and research to improve care for people with psoriasis and PsA. This World Psoriasis Day activity is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, CeraVe, Janssen and Novartis.
Join us for a conversation about types of vaccines and what's appropriate for use with immunosuppressive therapy. Dr. Sandy Chat from Indiana University School of Medicine and Dr. Christoph Ellebrecht, Clinical Instructor, Dept. of Dermatology at University of Pennsylvania, discuss the flu, shingles and mRNA vaccines. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Bullying may not be what you assume it is. Hear renowned psychologist Dr. Catherine Sanderson, Department of Psychology, Amherst College, address bullying that impacts youth and adults from types of behaviors, the bystander effect, and what actions can defuse bullying and build allies for a more positive environment. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Listen to this exciting update about the biggest treatment developments for biologics, oral agents and topicals for psoriasis and psoriatic arthritis. Leading dermatologist Dr. Andrew Blauvelt, President of Oregon Medical Research Center in Portland shares clinical results, pathways, and why he's excited about such developments! This activity is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen and Novartis.
Is it plaque psoriasis, guttate psoriasis or both? Hear dermatologist and NPF Medical Board member Dr. G. Michael Lewitt from Illinois Dermatology Institute in Chicago discuss five types of psoriasis including symptoms, locations and treatment options. Newly diagnosed or not sure what type you have, this podcast is for you! This episode is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen and Novartis.
Join us for a discussion about collaborative care from the perspective of dermatologist and epidemiologist Dr. John Barbieri, Brigham and Women's Hospital in Boston, and NPF Board Chair Ron Grau. Hear how such care can be implemented and what can be done to shift siloed care to working as a team to improve your health outcomes. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Listen to a fascinating update about genetic signals, familial risk and the work that's being done to understand how psoriasis and psoriatic arthritis develop from leading dermatologist and geneticist Dr. James T. Elder, Kirk D. Wuepper Professor of Molecular Genetic Dermatology, University of Michigan, Department of Dermatology. This episode is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen and Novartis.
Personalized medicine, latest treatments such as IL-23, TK2 inhibitors and a novel treatment in phase 2 clinical trials are just part of the latest news for psoriatic arthritis provided by rheumatologist Dr. Asim Khan with Voyage Healthcare in Maple Grove, MN. Psound Bytes is supported by unrestricted educational grants from AbbVie, Amgen, Bristol Myers Squibb, Janssen, and Novartis.
Hear why the gut microbiome is important and what's the latest research exploring the Gut-Joint-Skin axis from rheumatologist and leading expert in the microbiome, Dr. Jose Scher, Director of the Psoriatic Arthritis Center and Director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Health. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Join us for a discussion with dermatologist Dr. Robert Kalb, Clinical Professor, Dept. of Dermatology at SUNY, Buffalo School of Medicine in Buffalo, NY, about hard-to-treat areas such as psoriasis on the nails, ears, nose, eyes, mouth and pustular psoriasis. Hear his message of hope for hard-to-treat areas. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Lesions, cracks and splits on the feet? Pain in the Achilles tendon?Listen as podiatrist and foot and ankle surgeon, Dr. Matthew Paden from Rocky Mountain Foot and Ankle Center in Wheat Ridge, CO addresses issues related to psoriasis, psoriatic arthritis and foot care. This episode is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
"Increasingly we're seeing psoriasis is also a disease of the brain causing depression and anxiety" says Dr. Evan Rieder, dermatologist and psychiatrist at NYU Langone Health. Hear more about this biological connection, forms of anxiety and how cognitive behavioral therapy can help overcome self distortions about living with psoriasis. This episode is supported by unrestricted educational grants from AbbVie, Bristol Myers Squibb, Janssen and UCB.
In this episode, the NPF Advocacy Team breaks down a new insurance trend called "copay accumulator adjustment programs". These programs make it harder for patients to afford their treatments because copay assistance is no longer counting toward the deductible or out-of-pocket maximum. Request a free copay accumulator adjustment program resource at www.psoriasis.org/copay-accumulator or email the NPF Advocacy Team at action@psoriasis.org.
Hear Corey's journey with moderate-to-severe plaque psoriasis and the physical, social and emotional impact it had on his life. Dr. April Armstrong, Associate Dean of Clinical Research at the Keck School of Medicine at USC, joins to offer advice for how to manage your symptoms and discusses a treatment option for moderate-to-severe plaque psoriasis. This episode is sponsored by Sun Pharma. For more important Safety Information: https://bit.ly/2We7fIS .
From diagnosis to management psoriasis and psoriatic arthritis are similar but also distinctly different. Hear why from dermatologist Dr. Erin Boh, Tulane University School of Medicine in New Orleans, and rheumatologist Dr. Elizabeth Perkins from Rheumatology Care Center in Birmingham, AL. Psoriatic Arthritis Action Month is supported by unrestricted educational grants from AbbVie, Amgen, Bristol Myers Squibb, Janssen and Novartis.
Exercise is important but what if you have chronic pain and fatigue? Physical Therapist and Orthopedic Clinical Specialist, Pam Bohling with Mountain States Hand and Physical Therapy in Colorado addresses this key issue and what's essential for joint friendly exercises from a physical therapist. Psoriatic Arthritis Action Month is supported by unrestricted educational grants from AbbVie, Amgen, Bristol Myers Squibb, Janssen and Novartis.
"People with psoriatic disease are sleeping less and not as well" per dermatologist Dr. Tina Bhutani, Co-Director of the Psoriasis and Skin Treatment Center and Director of the Dermatology Clinical Research Unit at UCSF. Hear Dr. Bhutani discuss why, types of sleep disorders, effects and tips to help improve sleep. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Hear NPF Youth Ambassadors Sam and Jensen tell their story about being diagnosed, living and coping with psoriatic disease, and why they chose to become an inspiration to all as volunteer Youth Ambassadors! Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
If you have psoriasis and psoriatic arthritis you don't have to feel alone or overwhelmed by your disease journey. Hear from trained mentor Pattie and her mentee Andie how NPF's One to One Program offers peer support, ideas and inspiration for those with psoriatic disease. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Curious about celiac disease and if it's connected to psoriasis or psoriatic arthritis? Hear Brittany Link, registered and licensed dietitian at Advice for Eating in Houston, TX discuss symptoms, diagnosis, how CD differs from gluten sensitivity, and what to do if you think you have celiac disease. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen, Novartis, Pfizer and UCB.
Hear myth buster, dermatologist and rheumatologist Dr. Joseph Merola from Brigham and Women's Hospital in Boston give the facts about common myths associated with psoriasis and psoriatic arthritis and what it means for you, our listeners! Includes discussion about treatment remission and where we now on the path to a cure. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB.
Dr. Elizabeth Perkins, founder of Rheumatology Care Center in Birmingham, AL, joins us to discuss different forms of arthritis, including psoriatic arthritis. Learn about the differences between each condition and the resources available to get on the path to diagnosis. This podcast episode is sponsored by Novartis Pharmaceuticals Corporation, which compensated Dr. Perkins for her time. For more information visit www.PsARealTalk.com.
Curious about the research funded through the NPF? Hear about key research initiatives such as the PsA Diagnostic Test Grant and the Psoriasis Prevention Initiative along with the latest updates from Dr. Stacie Bell, Chief Scientific and Medical Officer, and Jackie Domire, Associate Director of Research and Medical Affairs. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB.
Join us as we celebrate Founder's Week with a look at the then and now of psoriasis management with Pete Miller, a member of NPF's Board of Directors and former school principal who has lived with psoriasis for 59 years. Hear Pete's incredible story, his challenges and how psoriasis treatments have changed so much over the years. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB.
Curious about MyPsoriasisTeam? Join co-founder and CEO Eric Peacock and MyPsoriasisTeam members Laurinda Knight, Vanessa Scott and Paul Gallant to hear how MyPsoriasisTeam has been paramount in their journey with psoriasis and psoriatic arthritis. While you are at it join the free community here: https://bit.ly/3pklYyh. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB.
COVID-19 vaccines have arrived! COVID-19 Task Force Co-Chairs, dermatologist Dr. Joel Gelfand, Psoriasis and Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Psoriasis Center, University of Rochester Medical Center return to discuss vaccine safety, effectiveness, and use with psoriatic disease treatments. This program is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB.
Join us as Psound Bytes celebrates two years of great podcasts by highlighting favorite episodes selected by you our listeners! Listen to see if your favorite episodes are included like the "Emotional Side of Psoriatic Disease" or "Heart and Psoriatic Disease Connection". You'll also receive a hint as to what's coming in 2021! This program is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB.
Listen as members of the NPF Advocacy team untangle the results of November's federal and state elections. Hannah and Patrick will also discuss what impact the results will have on those living with psoriatic disease and how they will influence NPF's Advocacy efforts over the next few years. Learn more at psoriasis.org/take-action.
Do you have a sudden flare of psoriasis with small drop like plaques over large areas? You may have Guttate Psoriasis. Listen as dermatologist and dermatopathologist Dr. Steven Feldman, Wake Forest School of Medicine in Winston-Salem, NC, addresses prevalence, triggers such as strep infection, and potential treatment options. This program is supported by unrestricted educational grants from AbbVie, Amgen and Lilly.
If you have generalized pustular psoriasis and/or palmoplantar pustular psoriasis you know how much this form of psoriasis impacts your life. Hear dermatologist Dr. Kristina Callis Duffin from the Department of Dermatology at the University of Utah discuss potential triggers, treatments, what to avoid and future treatments for GPP and PPP. This program is supported by unrestricted educational grants from AbbVie, Amgen and Lilly.
Hear dermatologist and rheumatologist Dr. Joseph Merola, Brigham and Women's Hospital in Boston, discuss a topic that's often hidden and tough to bring up - genital and inverse psoriasis. Listen as symptoms, confusion with other diseases, impact, and treatment options are addressed. This program is supported by an unrestricted educational grant from AbbVie, Amgen and Lilly.
Given the pandemic and how it's changed our world, it's tough not to feel anxious, stressed, overwhelmed or even depressed. Such feelings can make psoriasis worse. If this is how you feel, listen to our 100th episode as Licensed Professional Counselor Mary Maraventano Stried from Chicago, offer tips to change the impact and how we can reinvent our view of stress. This program is supported by charitable contributions from Bristol Myers Squibb.
Hear Charles discuss his 40-year journey with moderate-to-severe plaque psoriasis and how he advocated for himself when choosing a treatment. Meg McCoy, Senior Manager of Patient Support Services at Sun Pharma, also shares pertinent information on a treatment for moderate-to-severe plaque psoriasis and Sun Pharma's patient resources. This podcast episode is sponsored by Sun Pharma. For Important Safety Information: https://bit.ly/2We7fIS .
Hear rheumatologist Dr. Niti Goel, Duke University School of Medicine in Durham, NC discuss factors that impact clinical trials from inclusion of diversity in recruitment and process, to benefits and risks in participating. Be informed and be involved in steps towards a cure! This World Psoriasis Day activity is supported by charitable contributions from AbbVie, CeraVe, Janssen Pharmaceutical Companies of Johnson & Johnson, Lilly and Novartis.
Topicals are the most commonly used therapy for psoriasis. Hear why and what the therapy options are during a discussion of the sixth "Guidelines of Care for the Management of Psoriasis" from dermatologist Dr. Elizabeth Prater, Medical Director, Healthy Skin Dermatology in Oklahoma City. Includes a quick discussion of alternative medicine. This guideline activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.
Have you or a family member recently transitioned to Medicare or have questions about out-of-pocket costs for prescription drugs? Listen as NPF staff discuss the common challenges the psoriatic disease community commonly experience with Medicare Part D. Learn more about Part D's structure, if the donut hole has really closed, and options to address your out-of-pocket costs. Visit psoriasis.org/take-action for more information on NPF's advocacy.
When the pandemic shut down New York, Cindy found herself working and schooling her sons at home and managing her psoriasis. Fortunately, she discovered telehealth. Hear her story, and Dr. Jennifer Soung who uses telehealth in her practice, as they provide their perspectives on virtual healthcare. This podcast is sponsored by Amgen. For important Safety Information: https://bit.ly/2CzZ6Ym and for Prescribing Information: https://bit.ly/3hclnuA.
Feeling stress, anxiety or depression? Hear Dr. Theodore Stern, Chief of the Avery D. Weisman, Psychiatry Consultation Services at Harvard Medical School, and Dr. Arianne Shadi Kourosh, Assistant Professor of Dermatology at Harvard Medical School discuss strategies you can use to change your perspective of such emotions to truly face psoriatic disease. This episode is supported by unrestricted educational grants from Lilly and Novartis.
Have you ever had to try other medications before you get the one you and your doctor originally chose? This is called step therapy. Listen to this podcast to learn how NPF and others are advocating for federal step therapy legislation called the "Safe Step Act". Learn more at psoriasis.org/take-action or if you are experiencing step therapy, contact the Patient Navigation Center at education@psoriasis.org.
Hear the facts about this controversial and rapidly evolving topic, medical use of cannabis-based products for chronic pain with dermatologist Dr. Jason Hawkes, Assistant Professor of Dermatology at the University of California, Davis. Listen to Dr. Hawkes discussion about key components, actions, effects, interactions and how it relates to chronic pain in psoriatic disease.
Listen as pulmonologist, Dr. Albert Rizzo, Chief Medical Officer at the American Lung Association and member of Christiana Care Pulmonary Associates in Newark, DE, and Deb Brown, Chief Mission Officer with the American Lung Association, discuss the relationship between lung health, systemic inflammation and psoriasis. This episode also includes a free special offer for our listeners from the American Lung Association! Listen to learn more about this free offer!
Take action during Psoriasis Action Month by learning why it's important to participate in the PsoProtectMe global survey. Hear from Professor Catherine Smith, Professor of Dermatology and Therapeutics and Consultant Dermatologist, and Dr. Satveer Mahil, a Consultant Dermatologist, from St. John's Institute of Dermatology, Kings College London, about how this survey can advance our understanding of COVID-19 and other factors that impact the management of psoriasis and psoriatic arthritis.
With COVID-19 telehealth became more prevalent in use and with this pivot came challenges and benefits. Hear dermatologist Dr. George Han, System Medical Director for Dermatology at Mount Sinai Health System and Chief of Teledermatology at Icahn School of Medicine at Mount Sinai, discuss the challenges and tips for making telehealth visits with psoriatic disease a successful experience. This Psound Bytes activity is supported by charitable contributions from Amgen, Janssen Pharmaceutical Companies of Johnson and Johnson, and Novartis.
Wonder what choices are available for oral agents? Listen to a discussion of systemic nonbiologic therapies as addressed in the fifth "Guidelines of Care for the Management of Psoriasis" with preeminent dermatologist Dr. Kenneth Gordon, Professor and Chair of Dermatology at Froedtert and Medical College of Wisconsin in Milwaukee. The future of oral agents sounds promising! This guidelines activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.
The world as we know is changing daily and so did the traditional NPF Capitol Hill Day. Learn about the policies we supported to improve access to care for the psoriatic disease community and how easy it is to advocate from home. To learn more and join our efforts visit advocate.psoriasis.org.
Curious about what triggers psoriatic disease and what to do about flare management? Listen as Dr. Arianne Shadi Kourosh, Assistant Professor of Dermatology at Harvard Medical School and Dr. Theodore Stern, Chief of the Avery D. Weisman, Psychiatry Consultation Services and Professor of Psychiatry at Harvard Medical School, address the physical and emotional triggers that can flare psoriasis and psoriatic arthritis and what you can do to overcome this causality effect. This Psound Bytes activity is supported by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson.
Nail psoriasis affects up to 55 percent of people with psoriasis and it's tough to treat. Hear why it's difficult to treat and what options are available for managing nail psoriasis from leading dermatologist and NPF Medical Board member, Dr. April Armstrong, Director of the Psoriasis Program, Department of Dermatology at Keck School of Medicine, University of Southern California. This activity is supported by grant funding from AbbVie, Amgen and Lilly.
Hear what factors are considered beyond joint pain and location of psoriasis plaques when exploring a diagnosis of psoriatic arthritis from renowned rheumatologist and NPF Board Member, Dr. Elaine Husni, Vice Chair of the Department of Rheumatic and Immunologic Disease and Director of the Arthritis and Musculoskeletal Center at the Cleveland Clinic. Psoriatic Arthritis Action Month is supported by educational grant funding from AbbVie, Amgen, Bristol Myers Squibb, Lilly, Novartis and Pfizer.
Did you know psoriatic arthritis has six domains that represent musculoskeletal symptoms of the disease? Hear what those domains are along with how coordinated care such as "PPACMAN" can be of benefit to you from leading rheumatologist and NPF Medical Board Member, Dr. Evan Siegel with Arthritis and Rheumatism Associates in Rockville, MD. Psoriatic Arthritis Action Month is supported by educational grant funding from AbbVie, Amgen, Bristol Myers Squibb, Lilly, Novartis and Pfizer.
Kicking off Psoriatic Arthritis Action Month with a topic that affects so many people with psoriatic disease - fatigue! Hear dermatologist and rheumatologist Dr. Saakshi Khattri, Director, Center for Connective Tissue Diseases at the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai in New York, discuss the many nuances of fatigue from contributing factors to potential solutions. Psoriatic Arthritis Action Month is supported by educational grant funding from AbbVie, Amgen, Bristol Myers Squibb, Lilly, Novartis and Pfizer.
"I may have spots but I'm no different from any other kid." Diagnosed at two years old, hear Eddee and Zack Harrison's moving story about where it all started, how they live with psoriasis and what they do to help find a cure for psoriatic disease. Per Eddee "He may have spots, he may have psoriasis, but it doesn't matter. We can all work together to fight for a cure."
With COVID-19 there's so much information that's either true, false or just not clear! Hear the facts from special guest expert, pulmonologist Dr. Albert Rizzo, Chief Medical Officer at the American Lung Association and member of Christiana Care Pulmonary Associates in Newark, DE. Listen as Dr. Rizzo presents the current picture about COVID-19 from risk factors, symptoms and protective measures to possible treatments. You can also learn about helpful resources available through the American Lung Association from Chief Mission Officer, Ms. Deb Brown. For tips about maximizing telehealth appointments contact the National Psoriasis Foundation's Patient Navigation Center at education@psoriasis.org.
Listen to a discussion with Dr. Abby Van Voorhees, Chair of Dermatology at Eastern Virginia Medical School and Chair of the National Psoriasis Foundation's Medical Board about recent COVID-19 survey results that ultimately helped shape the development of the NPF Medical Board's "COVID-19 Recommendations for Patients with Psoriatic Disease". Includes discussion of about the use or discontinuation of systemic or biologic treatments.
During these troubled and dark times, we could all use words of inspiration. Hear the uplifting story and words of wisdom from volunteer Howard Chang who has lived with psoriasis for over 40 years. Listen to his approach to treatment options, flares, how being involved makes a difference, and why his mantra is "Don't Give Up". Link to participate in Take Action Tuesday's April 21 Facebook event: https://www.facebook.com/events/2519911738275989/.
Through this special episode learn what the Coronavirus means for you and your psoriasis and/or psoriatic arthritis. Hear answers to your questions from dermatologist, Dr. Mark Lebwohl , the Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mt. Sinai Health System in New York, and Dr. Stacie Bell, Chief Scientific and Medical Officer at the National Psoriasis Foundation.
Could your oral microbiome be driving your psoriasis severity or be a factor in development of the disease? Hear the latest research from dermatologists Dr. Benjamin Kaffenberger and Dr. Jessica Kaffenberger along with periodontist Dr. Purnima Kumar from Ohio State University, Wexner Medical Center. Includes a discussion about psoriasis in the mouth.
Curious about the impact of diet or supplements on your psoriasis or psoriatic arthritis? Hear the evidence and current research behind dietary recommendations for adults with psoriatic disease from renowned dermatologist, Dr. April Armstrong, Director of the Psoriasis Program, Department of Dermatology at Keck School of Medicine, University of Southern California.
'The risk is real but..." says Dr. Nehal Mehta, cardiologist and Chief of the Section of Inflammation and Cardiometabolic Diseases at the National Institutes of Health in Bethesda, MD. Hear Dr. Mehta discuss risks associated with cardiovascular disease, the metabolic arena, treatments and what can be done to reduce the risk of cardiovascular disease with psoriatic disease. All new information! This guidelines activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.
Does your scalp itch and flake? Is it red and have plaques? Don't traumatize your scalp further with aggressive plaque removal. Find the right treatment for you. Hear Dr. Jerry Bagel from the Psoriasis Treatment Center of Central New Jersey at Windsor Dermatology, discuss this and treatment options used to clear scalp psoriasis. This activity is supported by grant funding from AbbVie, Inc. and Lilly.
"Psoriasis had an impact on me because of my work" says Cyndi Lauper, award-winning singer, songwriter, actress and activist. Hear Cyndi Lauper's story about the challenges she faced at work due to her psoriasis, how she found a way to overcome her symptoms, and why she's speaking out on behalf of the PsO at Work campaign. For more information visit psoatwork.com. To share your story use #PSOatWork on your social media.
Hear how lifestyle choices and changes (i.e. Omega 6 vs 3, glycemic index, gluten and more) can impact or reduce the inflammatory response associated with psoriasis and related health conditions from Dr. Ronald Prussick, Medical Director at Washington Dermatology Center in Rockville, MD in this fascinating anniversary episode you don't want to miss! This guidelines activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.
Share in Dr. Lara Wine Lee's excitement as she presents an overview of the AAD NPF Management and Treatment of Pediatric Psoriasis Guidelines - the first of its kind. From the link to strep infection to treatment options, Dr. Wine Lee, Director of Pediatric Dermatology at the Medical University of South Carolina, shares just how bright the future is for youth with psoriasis. This activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.
A look at the different types of phototherapy treatment options from dermatologist Dr. Tina Bhutani, Co-Director of the Psoriasis and Skin Treatment Center at University of California San Francisco. Hear the options and why phototherapy still remains one of her favorite therapies for psoriasis. This activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.
Sarah and her husband share a love of fly fishing. But plaque psoriasis began to affect the activities she loved most. After trying topical treatments, she sought a second opinion and discovered a pill for moderate to severe plaque psoriasis. Hear Sarah share how she rediscovered her passion for the great outdoors by being open and honest about her psoriasis. This podcast episode is sponsored by Celgene. To see Full Important Safety Information: http://bit.ly/2IP7kMd. For Full Prescribing Information: http://bit.ly/33r0vYU.
Living with psoriasis and being in style sometimes presents challenges. By listening to the practical tips from blogger and extraordinary volunteer Alisha Bridges, you'll know that you can look your best and feel comfortable - all while dressing in the latest styles!
Having a chronic disease such as psoriasis adds nuances to a relationship that can make it more challenging for care partners and the person who has the disease. Hear some tips from psychologist and relationship coach Dr. Julie Shafer that just might make your relationships function with more understanding and harmony.
If you listened to episode 42 you heard mention of biosimilars from Dr. Barker. Now hear more about the development of biosimilars, how they compare to biologics and what's currently available from Dr. Grace Kimmel, who completed a fellowship in dermatopharmacology and is now with the Department of Dermatology at Icahn School of Medicine at Mount Sinai.
It's World Psoriasis Day! Hear a global view of issues that impact psoriasis and psoriatic arthritis - from access to treatment, stratification of psoriasis, the Global Psoriasis Atlas, and what all this means from dermatologist Dr. Jonathan Barker, current President of the International Psoriasis Council and Professor of Medical Dermatology at St. John's Institute of Dermatology, King's College in London, and Kathleen Gallant, a board member of the NPF who also serves as the board's representative with the International Federation of Psoriasis Associations (IFPA).
Have psoriasis and/or psoriatic arthritis? Are you pregnant or considering becoming pregnant? There are many factors and questions to consider from preconception, during and postpartum care. Hear about the risks and what you can do from Chair of NPF's Medical Board and dermatologist Dr. Abby Van Voorhees, Chair of Dermatology at Eastern Virginia Medical School in Norfolk, VA. This activity is supported by grant funding from UCB.
Curious how psoriasis and psoriatic arthritis impacts your emotions? There may be a physiological connection. Hear from Dr. Richard Fried, Clinical Director at Yardley Dermatology/Yardley Skin Enhancement and Wellness Center in Yardley, PA, address why the issue of mental health is of such importance that it was included in the psoriasis comorbidities guidelines released in February. Dr. Fried has a unique view since he is both a dermatologist and a clinical psychologist. This activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.
Since the first biologic appeared in 2002 for psoriatic arthritis, biologic therapy options have become more targeted in their approach. Hear world renowned dermatologist, Dr. Alan Menter, Chief of Dermatology at Baylor, Scott and White Health in Dallas, TX discuss the eleven biologics mentioned in the AAD NPF guidelines of care for the management and treatment of psoriasis with biologics. This activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.
In the middle of a psoriasis flare and have an urgent need to be clear? Listen to treatment options for rapid relief from one of the country's leading dermatologists, Dr. Mark Lebwohl, the Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai Health System in New York. This activity is supported by Lilly and AbbVie.
Psoriasis may be visible on the skin, but it is more than just a skin disease. Hear Dr. So Yeon Paek from Texas Dermatology Associate in Dallas, discuss the true impact of inflammation, what factors influence development of concurrent health conditions, and what you need to know and do to counter such impact. This activity is supported by an educational grant from Bausch Health Foundation.
Newly diagnosed? Curious about treatment options? Want help finding patient assistance programs or transitioning to Medicare and now your treatment is no longer covered? Listen as members of NPF's Patient Navigation Center offer sound advice as to how they answer such questions and more. You'll be surprised by what they do for you!
Is it possible to prevent psoriatic arthritis? That's the question asked of one of the country's preeminent rheumatologists, Dr. Christopher Ritchlin, Professor of Medicine and Co-Director of the Psoriasis Center at the University of Rochester Medical Center in New York. Hear his response and what he feels can be done to minimize joint damage and prevent psoriatic arthritis.
If you haven't heard about the glycome and glycan biomarkers, here's your chance to hear Dr. Emanual Maverakis, a dermatologist and physician investigator with the Departments of Dermatology, Medical Microbiology and Immunology at University of California, Davis discuss the altered glycan theory of autoimmunity and how glycan biomarkers may someday be used for the diagnosis and treatment of immune mediated diseases such as psoriasis.
Psoriasis in the ear can happen. Listen why it's challenging to treat, what the potential impact could be and what to do if you develop psoriasis in your ear from Chair of NPF's Medical Board and dermatologist Dr. Abby Van Voorhees, Chair of Dermatology at Eastern Virginia Medical School in Norfolk, VA.
Are you in need of switching psoriatic disease treatments? Learn what factors may indicate a change or discussion about treatment with your health care provider from dermatologist Dr. Junko Takeshita with Penn Dermatology and Assistant Professor of Dermatology and Epidemiology at the University of Pennsylvania, Perelman School of Medicine in Philadelphia.
Did you know bone loss and new bone formation occurs in psoriatic arthritis? Hear what cells are responsible for bone remodeling and the status of emerging osteoimmunology research from Dr. Iannis Immunology at University of California at Davis.
If you have psoriatic arthritis the chance of having a uveitis attack is 1 in 14. Hear rheumatologist Dr. James Rosenbaum, Chief of Arthritis and Rheumatic Diseases at OHSU and Chief of Ophthalmology at Legacy Devers Eye Institute describe what is uveitis, symptoms and why it's associated with psoriatic arthritis.
Not sure what type of arthritis you have? Hear a comparison of key features and symptoms of psoriatic arthritis to rheumatoid arthritis, osteoarthritis and gout from Dr. Arthur Mandelin, a rheumatologist with Northwestern University, Feinberg School of Medicine in Chicago.
This podcast is part of the PsA Action Month activities which is supported in part by Amgen, Bristol-Myers Squibb, Celgene, Lilly and Novartis.
Learn how the National Psoriasis Foundation's regional Advocacy Action Networks work to change or ensure legislative policies benefit people with psoriatic disease. Activities include step therapy reform, tackling rising out of pocket cost, Medicaid expansion and more. Hear about the issues and how many voices work collectively to achieve better policies for all.
Are you overwhelmed by over-the-counter product choices for psoriatic disease? Hear what to look for and practical tips for use from Veronica Richardson, a certified nurse practitioner with Penn Dermatology, Perelman Center for Advanced Medicine in Philadelphia.
Tiara may not have psoriatic disease but given her family connection she is quite familiar with concerns associated with the disease. At 13 years old she decided to do something and still chooses to raise awareness about psoriatic disease to this day. Hear how Tiara has made helping others her crowning achievement.
Don't miss Greg Kingsley's very compelling and inspiring story about how he overcame many challenges from being overnight, cancer, and treating his psoriatic disease to running half and full marathons. Greg truly runs his life!
Hear highlights from extraordinary volunteers Kathleen Browning and Thomas Dvorak as they share why volunteering is a family affair and what they do (and you can too) to help the National Psoriasis Foundation attain its mission. In honor of Volunteer Appreciation Week a sincere thank you to all our volunteers!
Hear why phototherapy is still considered an effective treatment option for psoriasis along with a more in-depth look at the Light Treatment Effectiveness or LITE Study. Dr. Joel Gelfand, Director of the Psoriasis and Phototherapy Treatment Center at University of Pennsylvania, expands on his conversation about the value of phototherapy and who makes a good candidate for the LITE Study.
Curious about the Light Treatment Effectiveness or LITE Study? Hear a preliminary conversation with Dr. Joel Gelfand, Director of the Psoriasis and Phototherapy Treatment Center at University of Pennsylvania, as he provides en"LITE"nment about what the study is, goals and how to become involved through this short podcast. (More details about phototherapy and the LITE study to arrive with the April 2nd episode.)
This may be a question you're tempted to ask. Hear Dr. Ronald Prussick, Medical Director at Washington Dermatology Center in Rockville, MD, provide the rationale behind why maintaining treatment and lifestyle changes are important to the systemic nature of psoriasis.
No sure which skin disease you may have? Hear Dr. Benjamin Lockshin, a nationally recognized dermatologist with Derm Associates in Rockville and Silver Springs, MD, explain the distinctions between psoriasis, eczema, seborrheic dermatitis, and other skin diseases.
Hear Dr. Meyer Horn, founder and Medical Director of Dermatology + Aesthetics in Chicago, discuss the heterogeneous nature of psoriasis and why some treatments stop working for some but continue for others.
Cyclist Josh Stelter shares his inspiring story about when he was diagnosed with psoriasis and how that discovery saved and changed his life. Hear how Josh turned frustration into opportunities to educate and help others with psoriatic disease. His positive spin on life may inspire you to look at life differently.
Learn what drives the heart and psoriatic disease connection and why even one plaque may be too much from Dr. Nehal Mehta, a cardiologist who is Chief of the Section of Inflammation and Cardiometabolic Diseases at the National Institutes of Health in Bethesda, MD. Dr. Mehta provides an update on his research around the impact of systemic inflammation using PET imaging.
Hear what the new treatment guidelines for psoriatic arthritis from the American College of Rheumatology and the National Psoriasis Foundation may mean for you. Dr. Philip Mease, a rheumatologist and Director of the Rheumatology Clinical Research Division at Swedish Medical Center/Providence St. Joseph Health in Seattle, WA discusses key points about the guidelines. This "New Psoriatic Arthritis Treatment Guidelines" episode is supported by Amgen and AbbVie.
This episode features Bonnie Duffy from the MAPRx coalition explaining the various mechanisms of the rulemaking process and providing examples of how programs like Medicare Part D are changed through regulation. Hear why it's important for you to know how regulatory policy is decided and learn more about how individuals living with psoriasis and/or psoriatic arthritis can impact such policy.
Wondering about treatment side effects? Hear the facts about psoriatic disease treatments from topicals to biologics from Dr. Ronald Prussick, Medical Director at Washington Dermatology Center in Rockville, MD.
Curious about biologic treatments for your child with psoriatic disease and what's coming in the future? Hear Dr. Amy Paller, world renowned pediatric dermatologist at Northwestern University, Feinberg School of Medicine address the use of biologics in youth along with her research in risk factors for cardiovascular disease and a novel approach to topicals via targeted gene suppression.